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Abstract 
A selection of commercially available mushrooms was obtained from Taiwan and 
screened for phenolic contents and antioxidant activity in aqueous extracts using 
v a r i o u s  c h e m i c a l  m e a s u r e m e n t s ,  n a m e l y  s c a v e n g i n g  o f  
2,2´-azinobis-(3-ethylbenzothiazoline-6-sulphonate) radical cation (TEAC), 
F e r r i c  r e d u c i n g  a n t i o x i d a n t  p o w e r  ( F R A P ) ,  s c a v e n g i n g  o f  
2,2-diphenyl-1-picrylhydrazyl radical (DPPH) and Folin-Ciocalteu reaction. 
According to the antioxidant activity perceived, Cordyceps militaris, Pleurotus 
citrinopileatus, Trametes versicolor, Hericium erinaceus, Ganoderma lucidum 
and Auricularia auricula-judae were selected for in vitro digestion and cellular 
antioxidant assay. After the in vitro digestion steps, the antioxidant activity in the 
extracts of C. militaris had significantly decreased, (in TEAC 22% and 27 % 
decrease, in hot- and cold-water extracts, respectively, in FRAP 42% and 21% 
decrease, in hot- and cold-water extracts, respectively and in DPPH 78% and 
21% decrease in hot- and cold-water extracts, respectively). The hot-water 
extract of A. auricula-judae and cold-water extracts of H. erinaceus showed no 
significant increase in TEAC assay after enzymatic digestion. There was a 
significant increase in antioxidant activity in the other mushroom extracts after in 
vitro enzymatic digestion. P. citrinopileatus exhibited the most potent antioxidant 
activity in the TEAC (from 24 to 2 times higher and 10 to 1.5 times higher than 
other mushrooms in hot- and cold-water extracts, respectively) and DPPH assays 
(from 6.4 to 1.2 times higher and from 27 to 1.6 times higher than the other five 
mushrooms in hot- and cold-water extracts, respectively) after digestion steps. T. 
versicolor showed the most potent ferric reducing power after digestion steps 
(from 29 to 5 times higher and 14 to 1.1 times higher than the other five 
mushrooms in hot- and cold-water extracts, respectively). These results indicate 
that most of the potential antioxidant compounds within the mushroom extracts 
could be released after digestion steps, whereas the potential antioxidant 
compounds of C. militaris might be degraded after digestion steps. 
The results suggest that determination of antioxidant activity in selected 
mushroom extracts may underestimate the real antioxidant activity that may be in 
close contact with the intestinal lumen. Chemical estimates of potential 
antioxidant compounds within the mushroom extracts may not accurately 
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indicate the complex nature of the antioxidant activity of mushroom extracts  
within cells. In this study, human hepatoma cell lines (Huh 7) were used to 
measure cellular antioxidant activity using 2´, 7´- dichlorodihydrofluorescein 
diacetate as a fluorescent probe. In artificially induced peroxyl radicals, among 
the selected mushroom extracts tested, C. militaris and T. versicolor had the 
highest cellular antioxidant activity, whereas H. erinaceus had the lowest. In 
addition, in chemical assays (TEAC and DPPH), the antioxidant activity of T. 
versicolor was less than that of P. citrinopileatus (64% and 67 % less in TEAC in 
hot-and cold- water extracts, respectively and 70% and 82% less in DPPH in hot- 
and cold-water extracts respectively). Even though the antioxidant activity of C. 
militaris was decreased after digestion steps, C. militaris exhibited far stronger 
cellular antioxidant activity than the other five mushrooms (p < 0.001). Based on 
the different antioxidant assay methods, the antioxidant activity of each 
antioxidant assay gave different antioxidant trends and antioxidant activity value 
depending on the type of extract method (hot- and cold-water extracts). Using 
cellular antioxidant assays may produce bioactivity results of the antioxidant 
activity of mushroom extracts within cells. These findings could suggest that the 
aqueous extracts from C. militaris and T. versicolor associated with health 
benefits and other traditional remedies, at least in part, might be their potent 
antioxidant activity. 
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Chapter 1 Introduction 
1.1 Oxygen and Free radicals 
1.1.1 The history of oxygen and the fact that oxygen is poisonous 
In the Earth’s crust, oxygen is the prevalent element whose accumulation into 
the atmosphere has forever changed the surface chemistry of the Earth resulting in 
the development of photosynthesis over three billion years ago. Cyanobacteria were 
the most primitive oxygenic photosynthetic organisms, and with their presence, the 
dawn of oxidative stress, one of the greatest selective pressures imposed on 
primordial life, commenced. In all living organisms, oxygen is essential for energy 
production, except for those organisms that live under anaerobic conditions. 
Oxidative stress is a universal phenomenon in all three domains of life, the archaea, the 
bacteria and the eukaryote (Canfield, 2005; Wiedenheft et al., 2005; Venturi and Venturi, 
2007). However, the presence of a greater concentration of oxygen than normal is toxic 
to plants, to animals, and to aerobic bacteria. In plants, an inhibition of chloroplast 
development and membrane damage caused by high concentrations of oxygen has 
been observed (Wroblewska et al., 1994). In Escherichia coli, growth is inhibited 
when the oxygen tension is increased in vitro (Brown et al., 1966). 
1.1.2 Definition of Free Radicals 
The outermost shell of a ground-state atom has complementary electrons which 
spin in opposite directions. An atom is considered to be ‘ground’ when its electrons fill 
the lowest energy orbital completely, and are arranged in pairs with antiparallel spin 
states before they begin to occupy higher energy orbitals. By definition, free radicals 
are any chemical species possessing one or more unpaired electrons in the 
outermost shell, and are capable of independent existence (Hanson, 2005; 
Fridovich, 2006) (Table 1). 
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Table 1: Different types of free radicals (Halliwell and Gutteridge, 2007). 
1.1.3 The Octet rule 
According to Lewis (1916), each bonded atom shares two or ‘paired’ 
electrons to form a stable molecule. Lewis (1916) called this discovery the ‘rule of 
two’, and subsequently Langmuis suggested the ‘octet rule’ (Jensen, 1984; Gillespie 
and Silvi, 2002). When a valence shell is filled completely and with eight 
electrons, the electron configuration corresponds to that of a noble gas, and the 
atoms are thought to be as stable as those of noble gases (Hanson, 2005; 
Fridovich, 2006). 
 
1.1.4 Free radical reaction 
When unpaired electrons are present, the free radicals are usually highly 
reactive, and not selective about what they react with. In chemistry, the classic 
route of the oxidative reactions of free radicals is divided into three distinct 
processes: initiation, propagation and termination (Hanson, 2005). 
Initiation: When free radicals react with surrounding compounds or molecules, the 
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reaction creates more free radicals. 
Propagation: The newly formed free radicals react with other compounds or 
molecules to form more free radicals. 
Termination: Theoretically, one free radical will encounter another free radical 
eventually. The reaction will be terminated when the unpaired electrons form a new 
covalent bond (Hanson, 2005; Fridovich, 2006). 
1.2 Reactive Oxygen Species (ROS) 
1.2.1 Definition of ROS 
Reactive oxygen species (ROS) are chemical structures, either stable or 
transient, containing oxygen atoms which are highly reactive in character due to the 
presence of unpaired valence shell electrons, and mediate extensive biological 
interaction. The free radicals which form reactive oxygen species are superoxide 
radicals (O2 ●-), hydroperoxyl radicals (HO2 ●), hydroxyl radicals (OH 
●), peroxyl radicals (ROO
●
) and alkoxyl radicals (RO
●
). However, not all ROS 
are free radicals. Several non-radicals are also designated as ROS. These non-
radicals include hydrogen peroxide (H2O2), singlet oxygen (O21), 
hypochlorous acid (HOCl) and ozone (O3). Other types of reactive species are 
reactive nitrogen species (RNS). Just like ROS, not only do RNS also have free 
radical forms such as nitric oxide (
●
NO) and nitrogen dioxide radical (
●
NO2), but 
also non radicals such as peroxynitrite (ONOO), peroxynitrous acid (ONOOH), 
peroxynitrate (O2NOO
‒
), nitronium cation (NO2 +) and dinitrogen trioxide (N2O3) 
(Aruoma, 1998; Halliwell and Gutteridge, 2007; Angelopoulou et al., 2009). 
 
1.2.2 Biological functions related to ROS 
ROS and RNS are ubiquitous and play an important role in all living 
organisms; ROS are by their nature by-products of normal metabolism, and both 
play a dual role as both deleterious and beneficial species. In normal 
circumstances, the endogenous production of ROS and RNS is essential for life 
(Droge, 2002). Small amounts of ROS and RNS are continuously produced in a 
normal biological system, and both play important roles in different biological 
functions such as signal transduction, neurotransmission, smooth muscle 
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relaxation, peristalsis, platelet aggregation, blood pressure modulation, the 
immune system control, learning and memory, production of energy, 
phagocytosis, the regulation of cellular growth, cellular signalling, the synthesis of 
important biological compounds and the metabolism of xenobiotics (Droge, 2002; 
Caporaso, 2003; Cooke et al., 2003). 
In the case of macrophage phagocytosis, when a foreign cell is engulfed 
during the processes of phagocytosis, the phagocyte increases its oxygen 
consumption, a process which is called oxidative or respiratory burst. In 
respiratory burst, superoxide is rapidly released and is converted from oxygen by 
NADPH oxidase and then converted to hydrogen peroxides by superoxide 
dismutase (SOD). In a third step, hydrogen peroxide is combined with a chloride ion 
to form bleach, ClO
-
 by myeloperoxidase. On the other hand, ROS at 
low/moderate concentration also induces mitogenic response (Hanson, 2005; 
Valko et al., 2007). The oxygen molecule is capable of accepting an additional 
electron to form more reactive oxygen superoxide. The ROS molecules contain 
oxygen ions that derive and present higher reactivity than molecular oxygen with 
redox activity such as O2 ●- and OH
●
 (Hanson, 2005). 
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Table 1.1 Important physiological functions that involve free radicals (Droge, 
2002). 
1.3 The source of ROS 
Free radicals are generated both naturally and from man-made sources 
(Halliwell, 1996). Antoine Lavoisier (1743-1794), the father of modern 
chemistry and a pioneer oxygen chemist who identified and named oxygen (1778) 
and hydrogen (1783), pointed out that “animals that respire are true combustible 
bodies that burn and consume themselves”. They operate just like an internal 
combustion engine producing nitric oxide and nitric dioxide (NO2) to pollute our 
atmosphere. However, the combustion in a biological system is much more 
complex than an internal combustion engine and harmful intermediates, the ROS, 
are produced (Sies, 1997; Finkel and Holbrook, 2000; Ou et al., 2003). 
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1.3.1 Environmental 
It is well known that the production of ROS may be compared to exposure 
to certain noxious factors such as some xenobiotic, infectious agents, pollution, 
UV light, cigarette smoke and radiation. In the environment, there are several 
causes of ROS generation directly or indirectly by physical, chemical and 
biological reactions (Hanson, 2005; Valko et al., 2006). For instance, when a 
molecule is exposed to a specific wavelength such as ultraviolet light, bond 
homolysis occurs and two electrons are divided equally to generate free radicals 
(Jurkiewicz and Buettner, 1994). In the body, water can be split to generate the 
hydroxyl radical (OH
●
) by low-wavelength electromagnetic radiation such as 
gamma rays from the environment. Although ultraviolet light is unable to split 
water, it can cleave the oxygen covalent bond in H2O2 (Halliwell, 1996). The 
human body can also generate free radicals such as O2 ●‒. Pollutant gases and 
smoking can lead to the increase of ROS activity in the human body (Abou‐Seif, 
1996; Proteggente et al., 2006; Valko et al., 2006). 
1.3.2 Cellular 
There are several other sources of ROS in living organisms. The 
mitochondrion is one of the major cellular sources of ROS production in the cell. 
In the mitochondrial electron transport chain (ETC), approximately 1% to 3% of 
total mitochondrial oxygen is incompletely consumed and that which is left leaks 
out of the pathway and passes directly to oxygen, leading to the generation of   
O2 ●- (Batandier et al., 2002). These redox reactions are carried out by four 
electron transporting complexes (I to IV) and one H
+
 - translocating ATP 
synthetic complex (V). In mitochondria oxidative phosphorylation, 
electrons are transferred from electron donors to electron acceptors. During 
the electron transport chain, when ubiquinone (coenzyme Q) accepts 
electrons to form ubisemiquinone, a highly reactive compound leaks out 
from the electron transport chain and ends up as stray superoxide. Two of the 
four mitochondrial complexes (I and Ш), the NADH-uiquinone 
oxidoreductase and the ubiquinone-cytochrome c oxidoreductase, are 
important sources of ROS production (Raha and Robinson, 2000). In addition, 
based on methods using nematodes, Ishii et al. (1998) suggested that the second 
mitochondrial complex (II) also produces superoxides. Under normal 
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physiological conditions, the rate of ROS generation is limited by high 
concentrations of the enzyme manganese superoxide dismutase (MnSOD) which 
ensures that the ROS can be efficiently removed keeping the rate of ROS 
generation at the basal level and resulting in little damage to biological systems 
(Raha and Robinson, 2000). It has been identified that within the mitochondrial 
complex I, the semiquinones act as donors for transforming O2 to O2 ●‒. Although 
the detailed mechanisms by which this mitochondrial complex converts electrons 
to vectorial protons are not apparent yet, laboratory evidence suggests that the 
increase of superoxide and hydrogen peroxide production in the mitochondrial 
complex might be due to blockage of the site where semiquinone donates an 
electron to an acceptor (Pitkanen et al., 1996; Pitkanen and Robinson, 1996; 
Raha and Robinson, 2000) (Figure 1).  
Enzymes such as xanthine oxidase are also capable of the production of O2 ● 
-(Kellogg and Fridovich, 1975). The important event in free radical generation in 
a biological system is the redox process that includes two reactions: oxidation 
and reduction. Oxidation is a process that donates electrons to an atom or 
molecule (donor) and reduction is a process that accepts electrons in an atom or 
molecule (acceptor). ROS also can be generated by metal redox systems such as 
Fe
2+
/Fe
3+
. Although H2O2 is not the major ROS, OH
●
 can be generated via the 
Fenton reaction (Fe
2+
 + H2O2 ↔ Fe3+ + OH
-
 + OH
●
) (Kirkinezos and Moraes, 2001) 
in which Fe
2+
 is a donor and H2O2 is an acceptor; the by-product OH
●
 is a strong free 
radical. The major generation of OH
●
 is from the interaction of hydrogen 
peroxide with transition ions, for instance Fe
2+
 and Cu
2+
 (Mantle and Preedy, 1999). 
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Figure 1: Intercellular ROS sources (Batandier et al., 2002). 
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1.4 Free radical damage 
1.4.1 Oxygen Stress 
In biological systems, maintaining the equilibrium of peroxidant/antioxidant 
operates like a balance. When ROS are over-produced in one site, enzymatic and 
non-enzymatic antioxidants maintain the balance in other site. When the balance is 
disturbed, the cumulative damage to proteins, lipids and DNA caused by excess ROS 
produced in the body leads to the occurrence of what is called ‘oxidative stress’, and 
this is believed to cause ageing and many human diseases (Sies, 1997; Droge, 2002; 
Ou et al., 2003). Numerous important metabolic and cellular disturbances are being 
linked to ROS when ROS overwhelm the normally efficient protective mechanism of 
cells and tissues. There is no doubt that ROS can cause lipid, DNA and protein 
damage (Hanson, 2005), and these will be discussed in greater detail next. 
1.4.2 Lipid damage 
Unsaturated fatty acids are the most oxidative labile components in a biological 
system due to unstable electrons near double bonds which are sensitive to lipid 
peroxidation where lipid peroxidation increases exponentially with the number of 
double bonds. (Barja, 2004; Valko et al., 2007). The CH2 group between carbon- 
carbon double covalent bonds is the major site in which ROS reaction occurs. The 
ROS can react with one of the CH2 giving water and a new radical species, lipid 
peroxyl radicals (LOO
●
). If lipid peroxyl radicals are formed, they can react with 
other lipids to form a lipid hydroperoxide (LOOH) and another lipid radical (L
●
) 
which can continue the oxidation reaction. This chain reaction can be thousands of 
events long, as demonstrated in the following reaction (Pardini, 1995; Hanson, 2005): 
LH + OH
●
 H2O + L● 
L● + O2 LOO
●
 
LOO
●
 + LH LOOH + L● 
1.4.3 DNA damage 
Free radicals can result in DNA damage which can cause mutation in oncogene or 
tumour suppressor gene generation. All components of DNA are known to react with 
hydroxyl radicals which result in single- and double-strand DNA breaks, purine, 
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pyrimidine base and deoxyribose modification, and DNA cross linkage (Halliwell and 
Gutteridge, 2007). Carcinogenesis is associated with the arrest or induction of 
transcription, the induction of a signal transduction pathway, replication error and 
genomic instability, which are all related to oxidative damage (Davey et al., 2000). 
Evidence of the production of DNA lesions has been accumulated to prove the 
relationship between oxidative stress and cancer (Hanson, 2005). For example, by 
studying 8-hydroxyguanine (8-OH-G), in cancer patients, the 8-OH-G extracted into 
urine is about 50% higher than in the control group (Rozalski et al., 2002). Exposure 
to asbestos, cadmium, hexavalent chromium, arsenic and tobacco smoke increases 
oxidative stress level and is considered to be potentially carcinogenic (Davey et al., 
2000; Hanson, 2005). 
1.4.4 Protein damage 
Compared with lipids, proteins are much larger molecules and have various 
structures and functions. When proteins are damaged, proteases hydrolysis the 
damaged proteins and recycle the atoms instead of repairing them. ROS damage 
proteins by two different mechanisms; the protein backbone is damaged first, 
followed by the side chains. For example, the sulphydryl or thiol groups (-SH) can be 
oxidized to form a disulphide bridge (-S=S-). However, when a -SH group cannot be 
formed into a disulphide bridge due to oxidation, the protein cannot fold up into its 
functional form. If some of the protein genes which turn off growth regulation are 
damaged, the faulty proteins may result in cells irregularly growing to form a cluster 
of cells and become cancerous (Hanson, 2005). 
1.5 Pathological Problems and Free Radical Generation 
In 1954, Gershman published the theory of oxygen toxicity of free radicals, and 
there are large evidences of proof that free radicals are not only adapted within the 
living biological system but also used in various physiological functions (Droge, 2002; 
Valko et al., 2007). Commoner et al (1954) discovered free radicals in biological 
material. Harman (1956) described free radicals as a Pandora’s Box of evils that may 
account for gross cellular damage, mutagenesis, cancer and the degenerative process 
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of biological ageing (Droge, 2002). Recently, ROS have been suggested to be the 
causative agents involved in a number of pathological processes such as diabetes 
mellitus, atherosclerosis, neurodegenerative disease, ischemia/reperfusion injury and 
many other diseases. Therefore, finding a critical concept for maintaining the balance 
between antioxidation and oxidation in biological systems is believed to be the most 
popular area in modern medicine (Droge, 2002; AshokKumar, 2004). 
1.5.1 Cardiovascular disease 
It has been suggested that atherosclerosis, ischemic heart disease, hypertension, 
cardiomyopathies, cardiac hypertrophy and congestive heart failure are linked with 
oxidative stress (Kukreja and Hess, 1992; Lakshmi et al., 2009). ROS-induced stress 
modifies phospholipids and thiol groups of proteins by peroxidation and oxidation, 
leading to changes in membrane permeability, membrane lipid bilayer disruption and 
the functional modification of various cellular proteins (Valko et al., 2007). Also, by 
incubating rat heart sarcolemma with hydrogen peroxide and Fe
2+
, Ca
2+
/Mg
2+
 ecto-
ATPase and sarcolemmal ATP independent Ca
2+
 binding activity are inhibited (Kaneko 
et al., 1989). A previous study had shown that exposure to xanthine plus xanthine 
oxidase or hydrogen peroxide caused rat heart mitochondrial creatine kinase activity to 
decrease (Hayashi et al., 1998). It may be concluded that increasing oxidative 
stress results in myocyte abnormalities, and this is suggested to be related to the effects 
of ROS on subcellular organelles (Angelopoulou et al., 2009). ROS induce intercellular 
Ca
2+
 overload which is directly or indirectly related to neointimal hyperplasia of 
atherosclerosis, vasoconstriction for hypertension, myocardial cell damage in 
ischemia reperfusion, as well as cardiac hypertrophy in heart failure, as has been 
revealed by many studies (Irani et al., 1997; Pérez et al., 1998; Podrez et al., 2000; 
Souza et al., 2000; Yuan and Li, 2003). As well as Ca
2+
 increase, Na
+
 
concentration and long-chain fatty acid accumulation in cardiac membrane are also 
suggested to be relevant (Valko et al., 2007). 
Lipid peroxidation leads to a decrease of membrane fluidity and results in 
damage to membrane proteins, inactivating enzymes and ion channels. The oxidized 
lipids can have a similar effect to H2O2, such as stimulating proliferation, blocking 
proliferation and inducing apoptosis and necrosis which occur in atherosclerosis, and 
maybe also be in the gastrointestinal (GI) tract (Halliwell and Gutteridge, 2007). Lipid 
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oxidization participates in orchestrating atherosclerosis (Farbstein et al., 2010). 
Enzymatic and free radical oxidations play important roles in cardiovascular disease. 
Because of oxidizable olefinic or double bonds, lipids are primary targets of oxidation 
(McIntyre and Hazen, 2010). 
The oxidized low-density lipoprotein cholesterol has been suggested as the 
atherogenic factor that contributes to cardiovascular disease. In the low-density 
lipoprotein (LDL) hypothesis, in the presence of high concentrations of LDL, the 
artery wall will be infiltrated by LDL, and the increasing LDL can be oxidized by free 
radicals. When LDL is taken up by a macrophage scavenger receptor, the formation of 
inflammatory cytokines and foam cells, the promotion of cell proliferation and 
cholesterol ester accumulation occur. When those cells accumulate in the blood 
vessels forming a fatty streak, this causes further endothelial injury and leads to 
atherosclerotic disease (Hanson, 2005; Liu and Finley, 2005; Singh and Jialal, 2006) 
(Figure 1.2). 
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Figure 1.2: The oxidized LDL process of atherosclerosis. ○X : oxidized LDL (Hanson, 2005). 
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1.5.2 Diabetes 
Diabetes is caused by faulty production of, or tissue response to insulin. Insulin 
signaling is a key part of the regulation of metabolism which may involve ROS. It has 
been suggested that increased activity of ROS and oxidative cellular damage are 
linked with diabetes (McCune and Johns, 2002; Praticņ, 2005). Oxidative 
phosphorylation, glucose autooxidation, NADPH oxidase, lipooxygenase, cytochrome 
P450 monooxygenases, and nitric oxide synthase (NOS) formation is stimulated by 
hyperglycemia caused by diabetic complications (Niedowicz and Daleke, 2005). 
1.5.3 Neurological disorders 
The brain is particularly highly susceptible to oxidative damage and this is 
considered to be related to several neurodegenerative diseases (Klein and Ackerman, 
2003; Ono et al., 2006). The brain is a high oxygen utilising organ: in adult humans, 
the brain consumes about 20% of basal O2 (Halliwell, 2006). With its high aerobic 
metabolic activity, polyunsaturated fatty acids and redox-active metals (such as Cu 
and Fe) make the brain particularly susceptible to oxidative damage. 
1.5.4 Alzheimer’s disease 
Evidence directly supports the belief that oxidative stress increases in the brain 
as a consequence of Alzheimer’s disease (AD) which includes an increase in the 
content of lipid peroxidation, a decrease in polyunsaturated fatty acids, protein and 
DNA oxidation, and the presence in activated microglia surrounding the most senile 
plaques of nitrotyrosine, formed from peroxynitrite (ONOO• –) (Halliwell and 
Gutteridge, 2007; Valko et al., 2007). 
Human brain studies have indicated that oxidative stress plays an important role 
in neuronal degeneration in AD. In AD, soluble amyloid beta-protein (Aβ), Aβ fibrils, 
neurofibrillary tangles (NFTs), mitochondrial abnormalities, and ageing are major 
contributors to increased oxidative stress. Imbalance in oxidative homeostasis has 
been suggested to be important factors in neurogenerative disorders such as AD 
(Chauhan and Chauhan, 2006) (Figure 1.3 and 1.4). 
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Figure 1.3: Possible mechanism of oxidative stress in AD: (A) under normal 
homeostasis conditions; (B) when ROS production overpowers the defence 
mechanism (Chauhan and Chauhan, 2006). 
 
 
Figure 1.4: Factors possibly involved in oxidative stress induced cell death in AD 
(Chauhan and Chauhan, 2006). 
1.5.5 Parkinson’s disease 
In Parkinson’s disease (PD), studies of post-mortem brains have shown that PD 
patients are subjected to oxidative challenge. PD involves the progressive death of 
substantia nigra cells which use dopamine (the neurotransmitter-chemical messenger 
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between the brain and nerve cells) to communicate with the stratium. Decreasing 
nigral dopamine levels lead to a decrease in stratial dopamine, which is believed to 
cause PD (Jenner, 2003). Oxidative stresses can cause dopamine cell degeneration in 
PD (Tretter et al., 2004). Mitochondrial dysfunction in complex I is also suggested by 
current evidence to play a potential and central role of excitotoxicity and oxidative 
stress in PD. The complex I inhibition is due to the production of nitric oxide (NO
●
) 
which interacts with the protein within complex I (Evans, 1993; Koutsilieri et al., 
2002). 
1.5.6 Ageing 
Two main theories have been proposed as processes forming ageing: 
damage-accumulation and genetic theories. The damage-accumulation theory suggests 
that the accumulation of free radical damage to DNA, lipids and proteins produced by 
free radical random deleterious effects is probably the most complex approach to 
explain the process of ageing. However, DNA damage is proposed as the most 
important process for ageing (Barja, 2004). Mitochondrial DNA (mtDNA) is the 
primary site of oxygen damage by superoxides. The damaged mtDNA cannot be 
readily fixed and the aftermath of the accumulation of damaged mtDNA causes cell 
death and organism ageing (Valko et al., 2007). Studies of maximum longevity and 
fatty acid unsaturation have shown a negative correlation (Pamplona et al., 2002). 
1.6 Defense system 
To help to counteract the oxidative challenge, the human body has a highly 
complicated antioxidant defence system composed of enzymes and vitamins to 
counteract the damaging power of ROS. In aerobic environments, there are three 
principal levels that maintain a steady-state of metabolites and functional integrity: 
prevention, interception and repair (Ou et al., 2003). 
1.6.1 Definition of Antioxidants 
Antioxidants have been defined by Halliwell as substances that are able, at 
relatively low concentrations, to compete with other oxidizable substrates and thus 
significantly delay or inhibit the oxidation of these substrates (Halliwell and 
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Gutteridge, 2007). Antioxidant defence systems in the human body can be categorised 
into endogenous antioxidant defences, and exogenous antioxidant defences 
(Hanson,2005). 
1.6.2 Endogenous antioxidants 
The endogenous antioxidant defences include enzymatic and non-enzymatic 
antioxidants. Among the enzymatic defences are superoxide dismutase (SOD), 
catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GR), 
peroxiredoxins (Prx) and thioredoxin reductase (TR) (Kahl et al., 2004). 
The O2 ●‒ is converted to O2 and H2O2 by SOD by the following reaction (Hanson, 
2005): 
SOD 
2 O2 ●‒ + 2H+ H2O2 + O2 
H2O2 is still an ROS and it is a powerful oxidant. Another enzyme, CAT, then 
converts H2O2 to water and O2 by following reaction (Hanson, 2005): 
CAT 
2 H2O2 2H2O + O2 
GPx also can react with H2O2 by using glutathione (GSH) to form water and a dimer 
of glutathione (GS-SG). The GS-SG consists of two GSH linked by a disulphide 
bridge which can be converted back to GPx by GR in the following reaction (Hanson, 
2005): 
GPx 
H2O2 + 2 GSH  _____________  2 H2O + GS-SG 
GR 
GS-SG + NADPH +H
+  __________________ 
 2 GSH + NAD
+
 
Prx reduces H2O2 and organic peroxides, and TR plays an important role in 
maintaining protein in reduced states. The non-enzymatic antioxidants include 
hormones, lipoic acid, uric acid, bilurbin, melanins, transferrin and lactoferrin (Tan et 
al., 2003; Halliwell and Gutteridge, 2007).   
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1.6.3 Exogenous antioxidants 
Plants produce numbers of antioxidant compounds (Hanson, 2005). Exogenous 
dietary antioxidants such as vitamin C, carotenoids and polyphenols are found in 
plants, fruits and vegetables. Epidemiological evidence suggests that consumption of 
an antioxidant-rich diet such as vegetables, fruits and tea may confer a significant 
effect on the prevention of chronic human disease coronary heart disease (Agarwal 
and Rao, 2000; Asplund, 2002). 
1.6.4 Polyphenolic compounds 
Polyphenolic compounds are a diverse group of ubiquitous compounds which 
can be found in all vascular plants. The common feature of phenolic compounds is at 
least a hydroxy-substituted aromatic ring. Several thousand different phenolic 
compounds have been characterized based on hydroxylated aromatic ring(s). Phenolic 
compounds are secondary metabolites that evolve in response to environmental stress 
such as pests and root parasitic nematodes (Boudet, 2007). Phenolic compounds are 
considered to have multiple biological effects in edible and non-edible plants. When 
plants are under oxidative stress, an abundance of antioxidants are produced such as 
tocopherol, ascorbate, glutathione, betanin, proline and many others regarded as plant 
defence compounds (Knekt et al., 1996; Kähkönen et al., 1999; Hanson, 2005; Shao et 
al., 2008). 
Any compound with one or more aromatic rings containing one or more 
hydroxyl groups is referred to as a phenolic compound. In 1800, Joseph Lister first 
used phenol as an antiseptic in surgical processes (Fisher and Arnold, 2004). In in 
vitro studies, most phenols act as chain-breaking peroxyl radical scavengers to inhibit 
lipid peroxidation. Phenols also inhibit other ROS such as OH
●
, NO2, N2O3, ONOOH and 
HOCl. Phenolic compounds form the majority of dietary antioxidants such as 
tocopherol, isoflavones in soybean, taxifolin in peanuts, resveratrol in wine, curcumin 
in turmeric and catechins in green tea (Halliwell and Gutteridge, 2007) . 
These antioxidant compounds are concentrated in the oxidation prone site of the 
plants. For example, the concentration of ascorbic acid found in chlorophyll can be up 
to 50 mM which is approximately 1000 times higher than the ascorbic acid found in 
human plasma (Davey et al., 2000). Several antioxidant compounds can neutralize 
ROS and pass along the extract electron until it resides in the stable molecule. For 
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example, when vitamin E reacts with ROS, the phenolic hydrogen is rapidly 
transferred to the ROS and forms a phenoxyl radical from vitamin E. Due to the 
aromatic amine structure, the phenoxyl radical is resonance stabilized and relatively 
unreactive to lipid or oxygen. Therefore, the chain reaction does not continue (Burton 
and Ingold, 1984) (Figure 1.5). 
 
Figure 1.5: The role of Vitamin E in quenching ROS and resonance stabilization 
(Hanson, 2005). 
It has been reported that polyphenolic families have different antioxidant abilities 
depending on their structure characteristics. Polyphenols are derived from two main 
synthetic pathways: the shikimate pathway and phenylpropanoid metabolism. At least 
ten different main classes of polyphenols have been listed according to their basic 
chemical structure. For example, simple phenol (C6) includes such compounds as 
phenol, cresol, thymol, resorcinol, orcinol, phenolic acid, with a C6-C1 structure, such as 
gallic, vanillic, syringic, p-hydroxybenzoic, and xanthones (C6-C1-C6), and the 
single most important group, the flavonoids (C6C3C6) (Figure 1.6) (Robards and 
Antolovich, 1997; Tapiero et al., 2002; Bravo, 2009). 
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Figure 1.6: Chemical structure of flavonoids retrieved from Gülçin (2012). 
The structure that fits the following three features would be effective in radical 
scavenging: (1) the O-dihydroxy structure in the B ring, (2) the 2, 3 double bond in 
conjugation with 4-oxo function in the C ring, and (3) the 3- and 5-OH group with 
4-oxo function in the A and C rings. Quercetin is the perfect example to demonstrate 
the criteria for effective radical scavenging (Rice-Evans et al., 1996) (Figure 1.7).
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Figure 1.7: The chemical structure of quercetin. 
Studies on the anti-inflammation, anti-allergenic, anti-carcinogenic, 
antihypertensive, anti-arthritic qualities and the inhibition of tumour promotion by 
phenolic compounds have been published to demonstrate their biological and 
pharmacological activities (Rice-Evans et al., 1997; Ma et al., 2006; Siedle et al., 
2007). Phenolic compounds are not only important in plants but also in animals. 
Phenolic compounds are present everywhere in the human diet: they are the 
constituents of fruits and vegetable, and are present in large amounts in beverages 
such as red wine, tea, coffee and beer. Approximately 1g of flavonoids is consumed in 
a balanced daily diet (Di Carlo et al., 1999). 
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Table 1.2: Examples of the therapeutic application of antioxidants (Augustyniak et al., 2010). 
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1.7 Introduction to Mushrooms 
Fungi are widespread, non-photosynthetic microorganisms whcih play an 
important central role in the functioning of the ecosystem, recycling energy and 
nutrients, and influencing the composition of a plant community (Newbound et al., 
2010). Fungi are also important food sources which provide nutrients such as nitrogen, 
minerals (Ca, Mg and K), and vitamins. In many different cultural groups and 
nationalities, people collect wild edible mushroom as food sources. There are about 
12,000 recognized fungi considered as mushrooms, and approximately 1000 species 
of edible mushrooms are recognized from 110 countries (Aida et al., 2009; Newbound 
et al., 2010). 
Around the world, about 35 species of mushrooms are cultivated commercially 
and Agaricus bisporus, Lentinus edodes, Pleurotus spp., Auricularia auricula-judae, 
Flamulina velutipes and Volvariella volvacea are world-wide the most commercially 
available mushrooms (Aida et al., 2009). Over 200 species have been collected from 
the wild and used for various traditional medical purposes, mostly in the Far East 
(Sanchez, 2004). For instant, Cordyceps spp., Tramete versicolor and Ganoderma spp. 
have been used in traditional Chinese medicine from historical times for a wide range 
of ailments (Ying, 1987; Ko and Leung, 2007; Newbound et al., 2010). L. edodes is a 
leading cultivated mushroom in China. Its production was 1,397.0 × 10
3
 tons in 1997, 
which is equal to 35.6% of the total national mushroom production (Chang, 1999). L. 
edodes was first cultivated in China between 1000 and 1100AD, and other less 
popular mushrooms even developed in China between 600 and 1800AD (Sanchez, 
2004). 
1.7.1 Health benefits of mushrooms 
In 1980, the term ‘functional food’ was first coined in Japan (Siro et al., 2008). 
According to a definition published by the US Academy of Science, functional foods 
are those which “encompass potential health products” including “any modified food 
or food ingredient that may provide a health benefit beyond the traditional nutrients it 
contains” (Smith et al., 2002). In China, mushrooms have been used not only as a 
source of food but also as a medicinal resource for over 2000 years (Cheung et al., 
2008). Since the 1980s, the term ‘medicinal mushroom’ has gained great attention 
after at least 270 species of mushrooms are known to possess various therapeutic 
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properties, and so can be considered as functional foods providing health benefits 
beyond the traditional nutrients they contain. For example, Cordyceps spp., G. 
lucidum, Phellinus linteus and Pleurotus spp. have been found to possess antitumour 
properties in vivo (Ohmori et al., 1986; Ying, 1987; Han et al., 1999; Shin et al., 2003; 
Cao and Lin, 2004). 
Mushrooms are low in calories, sodium, fat and cholesterol while containing 
high percentages of protein, carbohydrate, fibre, vitamins and minerals, and this 
makes them a very good dietary food, and they not only contribute to a well-balanced 
diet but also lead to significant health improvement (Aida et al., 2009). 
1.7.2 Current trends in mushroom use 
For their nutritional and culinary values, mushrooms are considered as functional 
foods and are used as tonics and medicines. Some traditional mushrooms such as 
Ganoderma spp. and Cordyceps spp. have been used by human for their medicinal 
and healing properties for many centuries. In Oriental medicine, mushrooms have 
long been part of prescriptions for treating atherosclerosis and other ailments (Cheung 
et al., 2008). According to the Food and Agriculture Organization of the United 
Nations (2009), in China, mushroom production had increased by about 65% during 
the pervious decade and more than 1.5 million metric tons were produced in 2007, 
followed by lower rates of production in the United States and Canada. The 
continuously increasing production of mushrooms and the increasing number of 
cultivated mushrooms being introduced into the market indicate high consumer 
demand and increasing awareness of the health benefits of mushrooms (Marshall and 
Nair, 2009). 
1.7.3 The history of herbs and mushrooms 
The term ‘ethnobotany’ was coined by Haoshberger in 1896. The definition of 
ethnobotany is “plants used by primitive and aboriginal people” (Nakanishi, 2005; 
Gurib-Fakim, 2006). In about 100BC, Shen Nong’s experience and work on herbs 
were eventually recorded in a book, the ‘Shen Nong Ben Cao Jing’, The Herbal 
Classic of the Divine Plowman (Chan, 1995). It is the earliest Chinese book on the use 
of herbs. In 1505AD, Liu Wan-Tai re-edited the book as ‘Pen Taso Ching’. In 1578, Li 
Shizhen wrote the Compendium of Materia Medica (‘Ben Cao Gang Mu’) which 
comprised 52 volumes, and mentioned 1892 herbs and 1000 prescriptions based on 
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Shen Nong’s Herbal. This book has made a great contribution to herbal therapies in 
China (Nakanishi, 2005; Gurib-Fakim, 2006). In Eastern Asian countries, especially 
in China, cultivating mushrooms for medicinal use has a long history, starting around 
600AD (Aida et al., 2009). 
In medicinal mushrooms, Cordyceps spp. are components of the Fuzheng Huayu 
recipe, a preparation containing herbs such as Salvia miltiorrhizae, Cordyceps spp., 
and seeds of Prunus persica (L.) Batsch, formulated on the basis of Chinese medicine 
theory in treating liver fibrosis (Ng and Wang, 2005; Liu et al., 2009). P. linteus has 
been used to prevent aliments such as gastroenteric dysfunction, diarrhoea and 
haemorrhage in China for centuries (Zhu et al., 2008). Ganoderma spp. is employed 
traditionally in Chinese medicine for treating hepatopathy, arthritis, hypertension, 
neurasthenia and chronic hepatitis (Liu et al., 2010). In traditional Chinese medicine, 
according to the Compendium of Materia Medica, T. versicolor is considered to be a 
useful treatment for dispelling heat, removing toxins and strengthening the physique 
(Chu et al., 2002). Wolfiporia extensa is often used in traditional Chinese herb 
prescriptions in combination with other crude drugs such as Banxia-Houpu for the 
treatment of diuretic conditions and depression (Luo et al., 2000; Yi et al., 2009). A 
number of mushroom species recorded in the Pharmacopoeia of the People’s Republic 
of China are Cordyceps spp., Ganoderma spp., P. linteus, and W. extensa (China 
Pharmacopoeia, 2005). 
1.7.4 Biosynthesis of phenolic compounds from mushrooms or fungi 
The shikimate pathway is found in prokaryotes, microbial eukaryotes and plants 
studies (Herrmann and Weaver, 1999). The shikimic acid pathway is the primary 
process which produces the aromatic amino acids, phenylalanine, tyrosine and 
tryptophan (Figure 1.9). In fungi, the phenolic compounds are secondary metabolites 
which are derived from the shikimic acid pathway. Fungi have distinct pathway for 
the biosynthesis of the aromatic amino acids because the enzymes, 
3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase, 3-Dehydroquinate 
dehydratase, and Shikimate dehydrogenase, are structurally different form the 
isoenzyme, which is encoded by part of the aromatic cluster (Figure 1.8) (Herrmann, 
1995). 
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Figure 1.9: Chorismate as a precursor for primary and secondary metabolites 
(Herrmann, 1995). 
The intermediates, chorismate, of the shikimate pathway are precursor of 
aromatic compounds including phenolic compounds. Through the shikimate pathway, 
phenolic compounds so derived in fungi are simple phenolic compounds. Depending 
on the carbon side chain, simple phenolic compounds are usually classified as C6-C3 
including cinnamic acid and its derivatives, C6-C2 including phenylacetic acid and its 
derivatives, and C6-C1, benzoic acid and its derivatives. 
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Figure 1.10: Structure of simple phenolic compounds. 
Studies of Lentinus lepideus have shown that the formation of cinnamic acid 
involves enzymatic conversion such as ammonia-lyases which convert phenylanine 
and tyrosine to cinnamic acid. To synthesize C6-C1 compounds, three possible 
pathways had been found. Studies on Sporobolomyces roseus have shown that C6-C3 
compounds, such as cinnamic, p-coumaric and caffeic acid, are converted into C6-C1 
compounds, such as protocatechuic acid, by â oxidation via benzoic and 
p-coumaric, and caffeic acids. Another pathway is the forming of protocatechuic acid 
and gallic aicd from dehydroshikimic acid. The third steps of C6-C1 formation 
involves a stepwise degradation of C6-C3 compounds converting them into C6-C1 
compounds via C6-C2 compounds, which has been demonstrated in Polyporus 
tumulosus (Cheung et al., 2008). The C6-C3 compounds are also intermediates in 
flavonoid biosynthesis, and the most important phenolic compounds with general 
character are in the diphenylpropane (C6-C3-C6) skeleton. In fungi, flavonoids have 
been also been found from Aspergillus candidus and Phallus impudicus, namely, 
chlorflavonin and dihydrochalcone respectively (Cheung et al., 2008; Hanson, 2008) 
(Figure 1.11). 
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Figure 1.11: The structure of flavonoids isolated from fungi (Hanson, 2008). 
1.7.5 Therapeutic aspects of mushrooms 
Medicinal and culinary mushrooms have been studied for their medicinal and 
therapeutic properties such as their antitumour, antiviral, antibacterial and antidiabetic, 
effects, their effect on cardiovascular disorders, and immunomodulation (Ions and 
Birmingham, 1992; Mizuno, 1996; Liu et al., 1999; Kim et al., 2004). 
1.7.5.1 Hypocholesterolaemic effect 
In 1966, in a ten-week study during which rats were fed with a high-fat, 
high-cholesterol diet supplemented with 5% dried weight of L. edodes, the plasma 
cholesterol level of the animals was decreased significantly (Tokuda, 1966). A more 
recent study showed that eritadenine (the adenosine derivate of lentinacin), isolated 
from L. edodes extract, is the active compound of the hypocholesterolaemic effect and 
is capable of reducing the serum cholesterol level in mice (Cheung et al., 2008). 
Eritadenine also accelerates the excretion of cholesterol and its metabolic 
decomposition and affects the metabolism of phospholipids and fatty acid in rats. 
Therefore, an eritadenine supplemented dietary may decreased phosphatidylcholine 
biosynthesis, suppressed Ä6-destraurase activity (Shimada Y, 2003) and lowered 
cholesterol by decreasing the ratio of phosphatidylcholine (PC) to 
phosphatidylethanolamine (PE) (Cheung et al., 2008). In other studies, animals were 
supplied with 2% and 4 % of Pleurotus ostreatus in a hyperlipidemic diet which was 
found to prevent cholesterol and triglyceride accumulation in both the blood and liver 
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(Bobek et al., 1991). The active cholesterol lowering agents isolated from P. ostreatus 
are well-known as lovastatin and its analogues 3-hydroxy-3-methyl-glutaryl-CoA 
(HMG-CoA) reductase. In a four week feeding experiment, two semisynthetic 
hypercholesterolaemic diets (1.5% cholesterol, 5% fat) each containing 5% dried 
powder of A. auricula-judae and Tremella fuciformis also had the ability to decrease 
serum total cholesterol (17% and 19%, respectively) and LDL cholesterol (24% and 
31%, respectively) in rats (Cheung, 1996b). 
1.7.5.2 Hypoglycaemic effect 
The active components of the hypoglycaemic effect of mushrooms are include 
polysaccharides and lectins (Kiho et al., 1995; Mori et al., 1998). The mushroom 
bioactive components such as endopolymers extracted from Cordyceps militaris, L. 
edodes, and P. linteus have been found to have a potential hypoglycaemic effect on 
streptozotocin (STZ)-induced diabetic rats. Fed with 50mg/kg (body weight) of 
endopolymers extracts for seven days, the rat’s plasma glucose was reduced by 18% 
after oral administration of endopolymers of L. edodes and P. linteus and 14% by C. 
militaris (Kim et al., 2001). Although â-glucans isolated from Agrocybe cylindracea, 
Grifola frondosa (the major components were galactose, glucose, fucose and mannose) 
and Hericium erinaceus (the major components of the extract were D-threitol, 
Darabinitol and palmitic acid) are different from one another, all the isolated 
polysaccharides displayed remarkable hypoglycaemic activity on diabetic model mice 
(Cheung et al., 2008). In another studying, in which STZ -induced diabetic rats were 
fed with 20% (dried weight) of G. frondosa, the initial fasting blood glucose of the 
control group was 225 mg/dL and the maximum blood glucose was 419 mg/dL 
(milligrams per decilitre), and the initial fasting blood glucose and maximum blood 
glucose of the diabetic rats were 170 mg/dL and 250mg/dL, respectively (Horio and 
Ohtsuru, 2001). Using intraperitoneal (IP) injection, two Agrocybe cylindracea crude 
polysaccharides extracts (HN1, high molecular weight, and HN2, low molecular 
weight) reduced the plasma glucose STZ- induced diabetic mice to 38% and 70% to 
control, respectively (Kiho et al., 1994a). Moreover, STZ-induced diabetic mice fed 
with the methanolic extract of H. erinaceus for successive days showed the ability to 
decrease the blood glucose by about 13% to 18% and by 19% to 26% than the non-fed 
group at dose rates of 100 and 200mg/kg respectively from day 5 through to day 20 
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(Wang et al., 2005). Lectins isolated from an edible mushroom (A. bisporus and 
Agaricus campestris) have also been found to enhance insulin sensitivity in isolated 
Langerhans islets in rats, and non-lectin components isolated from A. campestris 
present insulin-releasing and insulin-like activity (Cheung et al., 2008). 
1.7.5.3 Antitumour effect 
Letinan, a polysaccharide isolated from L. edodes, has shown an antitumour 
effect on Sarcoma 180-implanted mice at doses of 1mg/kg with no sign of toxicity 
(Chihara et al., 1970). Also, active polysaccharides isolated from P. linteus have 
significantly prolonged the survival rate of B16F-implanted mice and inhibited 
tumour growth in NCI-H23-implanted mice by giving IP injections at a dose rate of 
100mg/kg and active polysaccharides did not induce direct toxicity in cancer cells 
(Han et al., 1999). A compound 3 β -hydroxy-lanosta-8,24-dien-21-al,inotodiol 
isolated from Inonotus obliquus exhibited inhibition ability of about 23.96% and 
33.71% of tumour growth at concentrations of 0.1mg and 0.2mg per mouse per 
day in Balb/c mice bearing Sarcoma‐180 cells, compared with the control group 
(Chung et al., 2010). Agaricus subrufescens is one of the more newly discovered 
mushrooms. The ammonium oxalate-soluble extract from A. subrufescens exhibited 
the most tumoricidal activity on Balb/c mice receiving intradermal injections of 
Meth-A tumour cells by intratumoral administration at a concentration of 5mg (Ebina 
and Fujimiya, 1998). Shin et al. (2003) studied IP injection of ethanol extracts of 
Cordyceps sinensis, a traditional medicinal mushroom, and Paecilomyces japonica for 
nine consecutive days at concentrations of 50mg/kg and 100mg/kg. The inoculated 
Scarcoma-180 tumour cells in mice showed a significant decrease in tumour weights 
(40.4% and 42.3% at 50mg/kg and 47.7% and 49.5% at 100mg/kg, respectively) and 
volumes (39.5% and 28.1% at 50mg/kg and 47.6% and 46.7% at 100mg/kg, 
respectively). The life span of inoculated mice also had a significant increase with the 
median survival times (32.3 and 33.9 days for C. sinensis at concentrations of 
50mg/kg and 100mg/kg respectively, and 29.4 and 35.1 days for P. japonica at 
concentrations of 50mg/kg and 100mg/kg respectively, compared with a control group 
with 22.4 days) (Shin et al., 2003). 
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Figure 1.12: Possible pathways of lentinan action (Wasser, 2002). 
1.7.5.4 Immunomodulation 
Mushroom polysaccharides are regarded as biological response modifiers which 
exert their antitumour action mostly via activation of different immune responses in 
the host organism (Wasser and Weis, 1999). After administration of anti-lymphocyte 
serum, the antitumour activity of mushroom polysaccharides is lost in mice. This 
result suggests that the antitumour action of polysaccharides requires an intact T-cell 
and that the activity is mediated through a thymus-dependent immune mechanism. In 
addition, pre-treatment with antimacrophage agents (such as carrageenan) results in 
the antitumour activity of lentinan and polysaccharides being inhibited (Wasser, 
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2002). 
Secretions of active oxygen and production of cytokines in peritoneal 
macrophages are also activated by lentinan and it can increase peritoneal macrophage 
cytotoxicity against metastatic tumours. The antitumour ability may be linked with 
hormonal factors, which play an important role in tumour growth (Wasser, 2002). 
Studies of Ganoderma atrum have shown that G. atrum polysaccharide-induced 
tumour apoptosis through the mitochondrial pathway by altering Bcl-2 family proteins 
increases reactive oxygen species generation, loses mitochondrial membrane potential 
(∆ѱm), and releases cytochrome c from the mitochondria into cytosol (Li et al., 2011). 
It has been reported that the extract of C. sinensis has the ability to enhance the 
antibody response as judged by plaque-forming cells against T-dependent and 
T-independent antigens (Ng and Wang, 2005). Yamaguchi et al. (1990) reported that 
in tumour-bearing mice the C. sinensis extract restored the phagocytic activity of 
macrophages after tumour transplantation and lengthened the survival period. Studies 
of Cordyceps scarabaecola have shown that the water extracts have potential 
intestinal immune system modulating activity and the methanolic extracts manifest 
intermediate activity (Yu et al., 2003). Shin et al. (2001); Shin et al. (2003) 
demonstrated that the ethanolic extract of P. japonica stimulates phagocytosis and 
macrophage acid phosphatase activity. 
1.7.5.5 Antiviral, antibacterial and antiallergic 
Ganoderma annulare showed antifungal activity against Trichophyton 
mentagrophytes and G. lucidum presented active as an antiviral agent against human 
immunodeficiency virus type 1 (HIV-1) (El-Mekkawy et al., 1998; Smania et al., 
2003). In addition, antiviral activity against influenza virus type A has been found in 
Ganoderma pefeifferi (Mothana et al., 2003). The ability to inhibit allergic reaction 
has also been found in mushrooms. For instance, extracts of Hypsizygus marmoreus, F. 
velutipes and Pholiota nameko showed anti-allergenic effects in mice and G. lucidum 
inhibited histamine release from rat cells (Tasaka et al., 1988; Sano et al., 2002). 
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Figure 1.13: Possible immune mechanisms: â-D-glucan biological response modifier (Wasser, 2002). 
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Table 1.3: General compounds and effects of selected mushrooms. 
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Table 1.4: Selected medicinal mushrooms in traditional use and possible toxicity in China and Taiwan. 
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1.7.5.5 Potential use of mushrooms 
Several pharmaceutical preparations have been developed based on specific 
compounds of mushrooms such as the polysaccharides lentinan (from L. edodes), 
krestin (from T. versicolor) and maitake D-fraction (from G. frondosa) (Cheung et al., 
2008). In Taiwan, according to the Department of Health, cancer, cardiovascular 
disease and diabetes were the top three leading causes of death in 2011 (Yuan, 2012). 
In Taiwan, several types of selected culinary-medicinal mushroom product are 
available on the market today, such as A. subrufescens, C. militaris, T. versicolor, G. 
lucidum and H. erinaceus. However, only C. militaris and G. lucidum products have 
been licensed by Department of Health, Executive Yuan, R.O.C (Taiwan) and bear a 
label stating that a person using them for a specified health use may expect to obtain a 
health benefit through consumption (Department of Health Taiwan ). 
1.7.5.6 Toxicity 
Approximately, there are 50 to 100 mushrooms known to be poisonous to 
humans (Berger and Guss, 2005). Based on the principal toxins present in the variety 
ingested, clinically, mushroom toxins are divided into several groups. The principal 
groups are cyclopeptide, orellanine, monomethylhydrazine, disulfiram-like, 
hallucinogenic-indoles, muscarinic, isoxazole and GI-specific irritants (Table 1.4) 
(Berger and Guss, 2005). A. bisporus and Boletus edulis are frequently involved in 
human poisoning. Between January 1995 and December 2009, the Swiss toxicological 
information centre received 160 calls about A. bisporus, 305 calls about B. edulis 
poisoning and 24 calls about P. ostreatus (Schenk-Jaeger et al., 2012). 
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Table 1.5: Toxic mushrooms classification (Berger and Guss, 2005). 
AFR: Acute renal failure. 
1.8 Aims and Objective 
Mushroom extracts, therefore, have multiple and enormous therapeutic 
implications via a variety of mechanisms as discussed above. Mushrooms may be 
used directly as part of the diet to promote human health because of the synergistic 
effects of the bioactive compounds which are present in them. Mushrooms are 
ingredients widely used in the preparation of traditional Chinese medicine in China 
and Taiwan. Although research has so far focused on the therapeutic effects of  
speciality mushrooms, there is relatively little information about their antioxidant 
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properties and possible use in oxidative stress (Jayakumar et al., 2006). As an 
ingredient of traditional Chinese therapies, medicinal mushrooms are prepared in 
aqueous solution, and also most culinary mushrooms are prepared for consumption 
using aqueous methods (Chevallier, 1996). However, it remains unclear whether the 
beneficial effects of aqueous extracts of mushrooms are derived from their antioxidant 
properties. Therefore, the aim of this present study is to evaluate the antioxidant 
activities of medicinal and culinary mushroom extracts using crude extracts prepared 
according to traditional practices. Because the role of free radicals has been 
implicated in a large number of diseases as mentioned above, antioxidant activity is 
important in exploiting the potential therapeutic aspect of mushrooms. Proof of their 
antioxidant activity may also help to explain the mechanism of their therapeutic 
action. 
The objective of this study, therefore, is to evaluate the antioxidant properties of 
commercially available and cultivated culinary and medicinal mushrooms in Taiwan. 
The hypothesis is that the health benefits of mushrooms may be due to their potent 
antioxidant compounds. The first aim of the study is to screen mushroom extracts (hot 
and cold water extracts) for their potential antioxidant activity by using 
F o l i n - C i o c a l t e u  r e d u c i n g  c a p a c i t y  ( F C ) ,  2 ,  
2’-azinobis-(3—ethylbenzothiazoline-6-sulphonate) radical cation (TEAC), ferric 
r e d u c i n g  a n t i o x i d a n t  p o w e r  ( F R A P )  a n d  s c a v e n g i n g  o f  2 ,  
2’-diphenyl-1-picrylhydrazyl radical (DPPH) antioxidant activity assays to evaluate 
the relative level of antioxidant activity of these selected mushrooms. The selected 
mushrooms are used in Taiwan in culinary purposes, or are traditionally used to treat 
various disorders in which free radicals are thought to be involved, and by this means 
to provide comparable data. Since mushrooms accumulate a variety of secondary 
metabolites such as phenolic compounds, polyketides, terpene and steroids, the 
selected mushrooms were also investigated in terms of their antioxidant activity in 
relationship to their total phenolic contents. 
The phenolic compounds are one of the major group of primary antioxidants 
available for dietary as well as culinary purposes, consumption of mushrooms may 
provide potential antioxidant compounds, and the biological properties of potential 
antioxidant compounds depend on their bioavailability. The second aim, therefore, is 
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to investigate the in vitro availability of potential antioxidant compounds of 
mushrooms; the in vitro enzymatic digestion process will be employed to predict the 
release of potential antioxidant compounds of mushroom extracts within the human 
gastrointestinal tract (GI) tract system. The purpose of the present work was to 
evaluate potential antioxidant compounds released from traditional medicinal and 
culinary mushrooms using in vitro enzymatic digestion steps that mirror the human GI 
tract to observe whether GI condition could affect the antioxidant properties of 
mushroom extracts and to determine their stability during in vitro digestion. The 
objective was to investigate whether in vitro availability of those mushrooms could be 
used as a step prior to evaluating the antioxidant capacity. 
To improve the understanding of the potential antioxidant activity of mushroom 
extracts, the third aim is to use a cellular model to obtain biologically relevant data on 
the bio-accessibility of potential antioxidants in mushrooms. In this study, the 
potential antioxidant compounds of mushroom extracts will be investigated using 
2´-7´-dichlorofluorescin diacetate (DCFH-DA) as a fluorescent probe to estimate the 
cellular antioxidant activity and to compare the correlation between cellular 
antioxidant activity, total phenolic contents and chemical assays ( TEAC, FRAP and 
DPPH). Since there is no published data which provide the cellular antioxidant 
activity of mushroom extracts, using cell culture is an important step as it provides 
more biologically relevant data than data obtained from chemical-based antioxidant 
activity assays. This combination of several chemistry-based antioxidant assays, in 
vitro enzymatic digestion steps and cellular antioxidant activity assays could provide a 
more reliable assessment of antioxidant activity. 
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Chapter 2 Materials and Methods 
2.1 Materials and Chemicals 
2.1.1 Chemicals 
The chemicals used in this study were sodium acetate trihydrate 
(CH3COONa.3H2O), acetic acid (CH3COOH), 2,4,6-tripyridyl-s-triazine (TPTZ), 
hydrochloric acid (HCl), 2,2
´
-azobis (2-amidinopropane) dihydrochloride (ABAP), 
ferrous sulphate,ferric chloride (FeCl3.6H2O), sodium chloride (NaCl), sodium 
dihydrogen phosphate (NaH2PO4 +H2O), disodium hydrogen phosphate 
( N a 2 H P O 4 . 1 2 H 2 O ) ,  p o t a s s i u m  p e r s u l p h a t e ( K 2 S 2 O 8 ) ,  
2,2
´
-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), Trolox 
(6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid) , Folin-Ciocalteu (FC), 
sodium carbonate anhydrous and gallic acid, 2, 2-diphenyl-1-picrylhydrazyl radical 
(DPPH), 2´, 7´-dichlorofluorescin diacetate (DCFH-DA), glutaraldehyde, gentamic 
hepes, insulin, hydrocortisone, methylene blue, Hank’s Balanced Salt Solution 
(HBSS), trypan blue and quercetin dehydrate, pancreatin and pepsin and were 
purchased from Sigma-Aldrich. Dimethyl sulfoxide (DMSO) and acetic acid were 
obtained from Fisher Scientific. Foetal Bovine Serum (FBS), L-glutamine, PBS and 
penicillin/streptomcyin were purchased from PAA Laboratories Ltd. All other solvents 
were purchased from VWR International (Poole, Dorset, UK). 
2.1.2 Mushrooms 
All 29 mushrooms used in this study were purchased from China, Hong Kong, 
and from Nantou County and Chiayi County, Taiwan. The local mushroom farms, 
Taiwan, are all certificated with CAS label (Certified Agricultural Standards), and 
mushroom species are examined by Taiwan agricultural research institute, the Council 
of Agriculture, Taiwan. The mushrooms purchased from Peninsula farm with the 
support of The Chinese university and the funding from Innovation and Technology 
Commission, Hong Kong. The mushrooms from China were purchased from Liannan 
edible fungi research institute with the support with Guangzhou Agriculture 
technology research institute. The samples were freeze-dried before milling for use in 
assays. Since culinary and medicinal herbs are prepared for consumption using 
aqueous infusions/decoctions in traditional methods (Triantaphyllou, 2001), the 
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mushroom were prepared for measurement by aqueous extraction. 
2.1.3 Hot-water extract 
1g of each dried powdered mushroom was prepared by soaking in 20 mL 
de-ionized water (1:20 w/v) in a conical flask for thirty minutes then heating for thirty 
minutes in a boiling water bath. The extracts were filtered through Whatman No.1 
filter paper and the filtrates were centrifuged at 4000 x g (gravity) for ten minutes to 
remove insoluble materials. The filtrates were freeze-dried. 
2.1.4 Cold-water extract 
1g of each dried powdered mushroom was prepared by soaking in 20 mL 
de-ionized water (1:20 w/v) and shaking at room temperature at 150 rpm for 
twenty-four hours. The extracts were filtered through Whatman No.1 filter paper and 
the filtrates centrifuged at 4000 x g (gravity) for ten minutes to remove insoluble 
materials. The filtrates were freeze-dried. 
The antioxidant activity of the extracts was determined using TEAC, FRAP and 
DPPH assays. The results of the TEAC and DPPH assays were expressed as Trolox 
equivalent per gram dry weight (d.w.), and the results of the FRAP assay were 
expressed as ferrous ion equivalent per gram dry weight (d.w.). 
2.1.5 Selection of the mushrooms for in vitro enzymatic digestion and cellular 
antioxidant assay 
Based on the previously performed antioxidant assays (described in detail in 
section 2.1), mushrooms were categorised into three groups as having low, moderate 
or high antioxidant activities. According to Council of Agriculture, Executive Yuan , 
Taiwan (2007) , A. auricula-judae , H. erinaceus , and Pleurotus citrinopileatus are 
commonly consumed in Taiwan (Yuan, 2007). Medicinal mushrooms known only for 
their medicinal properties are decidedly non-edible because of their coarse texture and 
bitter taste (Editorial Board of Zhong-Hua-Ben-Cao (China Herbal), 1999). Two 
mushrooms were selected per group – one medicinal mushroom and one culinary 
mushroom. C. militaris (a traditional medicinal mushroom) and P. citrinopileatus (a 
culinary mushroom) have been categorised into group A (high antioxidant activity), T. 
versicolor (a traditional medicinal mushroom) and H. erinaceus (a culinary mushroom) 
into group B (moderate antioxidant activity) and G. lucidum (a traditional medicinal 
mushroom) and A. auricula-judae (a culinary mushroom) assigned to group C (low 
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antioxidant activity) (Figure 2.1). These selected mushrooms were subjected to in 
vitro enzymatic digestion to investigate activity during the simulated human GI tract 
digestion and cellular antioxidant activity assay. 
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Figure 2.1: Pictures of selected mushrooms for digestion and cellular assays. 
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Table 2.1: The origin of selected mushrooms. 
 
 64 
 
 65 
 
 
Table 2.2: Mushroom growing Substrates. 
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2.2 Antioxidant assays 
2.2.1 The Chemical assays 
During the past two decades, there have been many investigations into the 
antioxidant ability of plant materials or foodstuffs using several methods and 
strategies (Prior et al., 1998; Sánchez-Moreno, 2002). Because of the relationship 
between free radicals and human diseases, and the relevance that plant-derived 
antioxidants may have in mammals, a large number of investigations of the potential 
antioxidant capacities of traditional medicinal herbs, due to their long history of use 
and effects, have been conducted. For example, the rhizome of Salvia miltiorrhiza 
Bunge (Lamiaceae) (DanShen) in China is administered as a traditional Chinese 
medicine to treat diseases that are caused by oxidative stresses, for example ischemia 
and inflammation. In the Indian traditional medicine system (Ayurveda), Phyllanthus 
emblica L has been used for thousands of years in the treatment of several diseases or 
used as a rejuvenator to slow the process of ageing and related disorders. S. 
miltiorrhiza and P. emblica are known to scavenge free radicals (Scartezzini and 
Speroni, 2000; Auddy et al., 2003; Zhu et al., 2004). 
In general, most of the methods used to study antioxidants are based on 
generating free radicals in the presence of the antioxidant that potentially inhibits the 
oxidation of substrates (Sánchez-Moreno, 2002). Further, the mechanisms of oxidants 
and antioxidants are much more complex than one simple chemical assay. Different 
oxidants have different chemical and physical features that may cause antioxidants to 
respond to different oxidants or radicals with different redox mechanisms. Therefore, 
a single antioxidant assay cannot provide adequate data on the antioxidant ability of 
analytes. In order to elucidate the total antioxidant ability of analytes, using different 
antioxidant assay methods to evaluate the total antioxidant ability of the same sample 
is needed (Frankel and Meyer, 2000; Ronald et al., 2005). 
To determine the antioxidant ability of foods and biological antioxidants, based 
on simplicity, cost-effectiveness and easy accessibility, there are four frequently used 
methods: scavenging of 2, 2´-azinobis-(3—ethylbenzothiazoline-6-sulphonate) radical 
cation (ABTS
●+
) or trolox equivalent antioxidant capacity (TEAC assay), ferric 
reducing antioxidant power (FRAP assay), scavenging of 2, 2-
diphenyl-1-picrylhydrazyl radical (DPPH
●
 assay) and Folin-Ciocalteu reducing 
capacity (FC assay). A large number of antioxidant capacity evaluations of plant 
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material have been published based on these antioxidant assays (Triantaphyllou, 2001; 
Zheng and Wang, 2001; Hinneburg et al., 2006; Stratil et al., 2006; Wong et al., 2006a; 
Stratil et al., 2007; Wojdylo et al., 2007). Taking this into account, in this study, the 
levels of antioxidant activity of selected medicinal and culinary mushrooms were 
evaluated using FC, TEAC, FRAP and DPPH assays. 
2.2.2 Scavenging of 2, 2´-azinobis-(3—ethylbenzothiazoline-6-sulphonate) radical 
cation (ABTS
●+
) 
A modification of the TEAC assay was carried out using the method of Re et al. 
( 1 9 9 9 ) .  T h e  l o n g - l i v e d  r a d i c a l  c a t i o n  c h r o m o p h o r e  2 ,  
2´-azinobis-(3—ethylbenzothiazoline-6-sulphonate) radical cation (ABTS ● +) was 
generated by reacting ABTS stock solution with potassium persulfate. Specifically, 7 
mM of ABTS stock solution was mixed with 2.45mM potassium persulfate at a ratio 
9:1 (v/v) (both solutions were prepared in deionised water) and the mixture was 
allowed to stand in the dark at room temperature for twelve hours before use. The 
ABTS
●+
 working solution is stable for up to five days if refrigerated. For the study of 
mushroom antioxidant capacity, the ABTS ● + solution was diluted with 5mM 
phosphate buffer solution (PBS), pH 7.4, to an absorbance of 0.7 ( ± 0.2) at 734nm 
and equilibrated at 30°C. The assay was performed in a 96-well microplater reader. 
The protocol was as follows: 10µL (0.05mg/ µL) of mushroom extracts or Trolox 
standard solution were mixed with 290µL of ABTS
●+
 radical cation solution and 
incubated for six minutes at 37°C. The reduction of ABTS
●+
 radical cation by adding 
compounds that contain antioxidants was measured by the change of absorbance of 
ABTS
●+
 radical cation at 734nm (Figure 2.1). A standard solution of Trolox was 
prepared at a range of 0.1 to 0.5mM in ethanol (HPLC grade, BDH). The 
quantification of TEAC equivalent was calculated by reference to the Trolox solution 
on a molar basis (Re et al., 1999) (Figure 2.2). Additional dilution was needed if the 
TEAC value measured was over the linear range of the standard curve. A 
corresponding blank was treated in exactly the same manner as the other samples. All 
determinations were performed in triplicate (n=3) (Re et al., 1999). 
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Figure 2.1: ABTS reaction (Huang et al., 2005). 
 
 
 
 
 
Figure 2.2: TEAC Standard Calibration Curve. Each value is expressed as mean 
± standard deviation (n=3). 
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2.2.3 Ferric reducing antioxidant power (FRAP assay) 
The FRAP assay was first described by Benzie and Strain (1996). The method is 
based on measuring the reduction of the ferric 2, 4, 6-tripyridyl-s-triazine complex 
(Fe
3+
-TPTZ) to the intensely blue ferrous form (Fe
2+
-TPTZ) (Figure 2.3). The assay in 
this current study was carried out according to the method of Benzie and Strain (1996) 
with minor modification. Briefly, Fe
3+
-TPTZ was dissolved into 40mM hydrochloric 
acid to a 10mM of Fe
3+
-TPTZ solution, and the working solution was mixed with 
2.5mL of 10mM Fe
3+
 -TPTZ solution with 25mL of 300mM sodium acetate buffer of 
pH 3.6 (3.1g sodium acetate an 16mL acetic acid per litre), plus 2.5mL of 20mM 
ferric chloride (FeCl3.6H2O). Then 2mM of ferrous sulphate standard solution was 
diluted to a range from 0-1000µM in deionised water. An aliquot of 10µL (0.05mg/ 
µL) of mushroom extract (or ferrous sulphate standard solution or water for blank) 
was mixed with 300µL of FRAP working solution and incubated at 37°C for four 
minutes. FRAP absorbance values were measured at 593nm over the incubation 
period solution using a 96-well microplate reader and relating it to a ferrous iron 
standard (Figure 2.4). Additional dilution was needed if the FRAP value measured 
was over the linear range of the standard curve. A corresponding blank was treated in 
exactly the same manner as the other samples. All determinations were performed in 
triplicate (n = 3) (Benzie and Strain, 1996). 
 
Figure 2.3: FRAP Reaction (Huang et al., 2005). 
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Figure 2.4: FRAP Standard Calibration Curve. Each value is expressed as mean 
± standard deviation (n=3). 
2.2.4 Scavenging of 2, 2-diphenyl-1-picrylhydrazyl radical (DPPH
●
 assay) 
A modification of the 2, 2-diphenyl-1-picrylhydrazyl radical (DPPH
●
) method of 
Brand-Williams et al. (1995) and Thaipong et al. (2006) was adopted (Figure 2.5). A 
concentration of 0.6mM of DPPH
●
 stock solution was prepared in methanol (HPLC 
grade, BHD) and stored at -20°C prior to analysis. The DPPH
●
 working solution was 
obtained by mixing 30mL stock solution with 80mL methanol to obtain the final 
concentration of 0.16mM. The solution was stored in a flask covered with aluminium 
foil, and kept in the dark at 4°C between the measurements. 10µL (0.05mg/µL) of 
trolox standard or mushroom extracts and 300µL of methanolic solutions of DPPH
● 
were mixed with 30µL deionised water as a diluter. The mixture was incubated for 
thirty minutes at 30°C in the dark. The decrease in absorbance was measured at 
517nm, using a 96-well microplate reader against a water or methanol blank. A blank 
sample containing the same amount of water or methanol and DPPH solution was 
prepared freshly. The absorbance values of the mushroom extracts were interpolated 
in a trolox calibration curve, and the antioxidant status of the test sample was 
expressed on a molar basis (Figure 2.6). Additional dilution was needed if the DPPH 
value measured was over the linear range of the standard curve. A corresponding 
blank was treated in exactly the same manner as the other samples. All determinations 
were performed in triplicate (n = 3) (Brand-Williams et al., 1995; Thaipong et al., 
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2006). 
 
Figure 2.5: DPPH assay (Molyneux, 2004). 
 
 
Figure 2.6: DPPH Standard Calibration Curve. Each value is expressed as mean 
± standard deviation (n=3). 
2.2.5 Folin-Ciocalteu reducing capacity (FC assay) 
The total phenolic contents of the mushroom extracts were assessed using the 
Folin-Ciocalteu phenol reagent as described by Zang Q. et al. (2006) with slight 
modification. Before the analysis, a commercial Folin-Ciocalteu phenol reagent was 
diluted with deionised water in 1:10 (v/v). 10µL of serial dilution of standard solution 
or each mushroom extract was pipetted into a 96-well micro plate and 130µL of 
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diluted Folin-Ciocalteu phenol reagent added and mixed well. After five minutes, 
100µL of 7.5% sodium carbonate solution was added. The absorbance at 750nm was 
measured thirty minutes after incubation at 40°C. Gallic acid was used as a reference 
standard at 100mg/L, and serial dilution was carried out accordingly at 100, 50, 25, 
12.5, 6.25, 3.125, 1.57 and 0.78µg ml
-1
 (Figure 2.7). The total phenolic contents were 
expressed as gallic acid equivalent (GAE) (Zhang et al., 2006). Additional dilution 
was needed if the FC value measured was over the linear range of the standard curve. 
A corresponding blank was treated in exactly the same manner as the other samples. 
All determinations were performed in triplicate (n = 3). 
 
Figure 2.7: Phenolic Content Standard Calibration Curve. Each value is 
expressed as mean ± standard deviation (n=3). 
2 .3 In vitro enzymatic digestion assay 
The GI tract is constantly exposed to harmful substances since humans may 
consume millimoles of various oxidation products per day (Halliwell and Gutteridge, 
2007; Corona et al., 2009; Halliwell, 2009). Vitamin C, vitamin E, carotenoids and 
phenolic compounds have often been suggested to have the ability to delay or prevent 
cancer development by being absorbed from the GI tract into the plasma and from 
there into the tissue, where they might decrease levels of oxidative DNA damage. 
High levels of phenols existing in the stomach, small intestine and colon could 
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therefore conceivably exert antioxidant and other protective effects there (Halliwell et 
al., 2000).However, the biological properties of these compounds are dependent on 
their bio-availability. In nature, these antioxidant compounds are normally present in 
foods and beverages in various chemical forms such as polymeric complexes. To access 
gut absorption, adequate degrading is required (Scalbert and Williamson, 2000; 
Troncoso, 2001; Serrano et al., 2005). The bio-availability of some phenolic 
compounds has been studied in humans by measuring their concentration in 
plasma and urine post-ingestion (Scalbert and Williamson, 2000). Some of 
these antioxidant compounds can be inert and digested as they pass along the human 
GI tract, a process that could perhaps degrade the antioxidant and pharmacological 
properties of the parent molecules by pre-absorption (Ryan and Prescott, 2010). 
A number of studies have shown that some phenolic compounds are present in 
human plasma and other biological fluids after absorption (Troncoso, 2001). Studies 
have also shown that hesperetin and naringenin, flavanones present in orange juice, 
can be detected in plasma with maximal concentration after the ingestion of the 
orange juice (Gil-Izquierdo et al., 2003). Another study has shown that the absorption 
of orally administered quercetin was 24%, while the absorption of quercetin glycoside 
from onion was 52%, 17% for querctein-3-rutinoside and 24% for quercetin aglycone 
(Hollman et al., 1995). It is therefore important to determine how the digestion 
process affects the potential antioxidant compounds and their stability. 
There has been a recent increase in research into understanding the fate of 
molecular, physicochemical and physiological processes during the consumption of 
food products which are believed to benefit human health (McClements et al., 2008). 
In order to extract the nutrients required for maintaining health, the human body has 
developed a complex system to break down foods. To simulate these physiological 
conditions, in vitro human GI tract delivery systems have been designed to release 
bioactive compounds at a specific location during digestion (Hur et al., 2011). 
Several applications of in vitro biochemistry models have been designed to 
provide rapid representative sampling at any time point instead of the complex, 
multi-stage process of human and animal studies which are technically difficult, 
ethically challenging and expensive to perform (Gil-Izquierdo et al., 2001; 
Pérez-Vicente et al., 2002; Nagah and Seal, 2005; Wickham et al., 2009). Many of the 
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in vitro models involve changes in pH and activity of proteolytic enzymes by 
acidification with hydrochloric acid, the addition of gastric enzymes followed by a 
varying delay simulating gastric residence time, neutralisation with sodium carbonate 
or hydroxide, and the addition of pancreatic enzymes and bile salts all the while 
stirring at 37°C (Wickham et al., 2009). Since it is well known that antioxidant 
activity can be strongly influenced by many factors (such as the antioxidant 
concentration, temperature, pH of the medium, and existing chemicals which may act 
either as positive or negative synergism), it would be interesting to evaluate the 
release of potential antioxidant compounds from mushroom extracts and possible 
chemical transformation due to the enzyme and pH condition of the stomach and 
small intestine (hydrolysis and other chemical transformations). 
After all these digestive treatments, the surviving antioxidants have to be 
absorbed and pass through the intestinal enterocyte barrier to reach the lymph or the 
blood. The ingested food matrix can considerably limit or enhance the absorption 
process. Mushrooms are rich in indigestible compounds such as polysaccharides 
which human intestinal enterocytes might not be able to absorb (Cheung et al., 2008; 
Soler‐Rivas et al., 2009). Therefore, the current study was designed to investigate the 
antioxidant availability of culinary and medicinal mushrooms after in vitro enzymatic 
digestion. 
2.3.1 In vitro enzymatic digestion procedure 
The in vitro enzymatic digestion steps were based on the method described by 
Aura et al. (1999) and modified by Nagah and Seal (2005). Briefly, 1mL of 
mushroom extract was placed in a 50mL plastic, screw-topped tube and five glass 
marbles added; 19mL of deionised water was added and the tubes were incubated in a 
shaking water bath at 37°C and at 90 stroke/min
-1
. After ten minutes, 10 mL of 0.05M 
HCl was added to each tube (simulating pH conditions in the stomach). After twenty 
minutes incubation, one mg pepsin dissolved in 0.5ml of HCl was added. Then after 
further 20 minute incubation, 1mL of 0.5M NaOH was added (simulating pH 
conditions in the small bowel). Finally, after 20 minutes, 5mL of pancreatin was 
added (from 3g of pancreatin dissolved in 20mL of deionised water, the tubes were 
centrifuged for ten minutes at 1500g and then 15mL of supernatant sufficient for three 
tubes, removed) was added and incubated for twenty minutes. Each extract was run in 
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triplicate. Aliquots of 1mL were taken from each tube immediately before each 
addition and stored at -20°C for antioxidant analysis. A corresponding blank was 
treated in exactly the same manner as the other samples for each experiment to detect 
if the reagents themselves had any antioxidant activity.  
 
2.4 Cellular antioxidant activity assay 
The representative dietary antioxidant examples such as vitamins, carotenoids, 
phenolics and flavonoids have been evaluated for their antioxidant ability using 
different measurement methods, many of which are chemical-based assays (Velioglu 
et al., 1998; Cai et al., 2004; Ozgen et al., 2006; Wojdylo et al., 2007). These methods 
do not address the uptake, distribution and metabolism of antioxidants in the cells. 
The lack of in vivo relevant results to predict the antioxidant activity is a critical issue 
(Wolfe and Liu, 2007). 
Natural antioxidants have been assumed to lead to decreased oxidative damage in 
key molecules as has already been stated. Many of the conclusions about antioxidant 
activity are based on chemical experiments, which are not necessarily reflected in the 
biological system (Wolfe and Liu, 2008). With different antioxidant properties, every 
available chemical-based assay has its specific benefits and drawbacks because each 
reaction is based on detecting the antioxidant interference caused by chemical 
reactions (Xu and Chang, 2010). For example, pure antioxidant compounds do not 
show any clear correlation between TEAC and FRAP values and the number of 
electrons that an antioxidant can react with oxidants. Ascorbic acid, α-tocopherol, 
glutathione and uric acid have similar TEAC values (Huang et al., 2005), however, 
normally glutathione donates one electron while the others donate more electrons. 
Quercetin and kaempferol have very different TEAC values although they have a 
similar chemical structure (Huang et al., 2005). FRAP results suggest that 1mol of 
ascorbic acid can reduce 2mol of Fe(III) and that 1mol of bilirubin can reduce 4mol 
Fe(III) (Huang et al., 2005). In contrast, both vitamin C and bilirubin are two-electron 
reductants (Huang et al., 2005). Genistein and daidzein have shown an effective effect 
on scavenging the ABTS free radicals in a TEAC assay but poor reducing power in a 
FRAP assay. Further, both of them had no activity in cellular antioxidant assays 
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(Huang et al., 2005). 
Living cells are protected from oxidative damage through several defence 
mechanisms such as the enzymatic conversion of ROS into less toxic substances and 
through detoxification by reaction with antioxidants (Cotgreave et al., 1988; Dean et 
al., 1993; Aruoma, 1996). Lipids are recognized as important compounds in various 
metabolic pathways and also important compounds of the cell membrane. When 
biological membranes are attacked by free radicals, the rheology of membrane lipid is 
changed, and it will affect several biological events. Exposing red blood cells to 
oxidative stress showed that inhibition of lipid peroxidation could provide little 
protection against protein modification (Lissi et al., 1991). These biological functions 
of lipid membrane are susceptible to ROS damage. Therefore, lipid peroxidation of 
membrane functions and the protective role of antioxidants in membranes have 
motivated this investigation. With rapidly increasing evidence suggesting that 
oxidative stress-induced damage is involved in many pathologies, a number of 
approaches have been developed to measure cellular oxidative stress, such as electron 
spin resonance (Ramos et al., 1992), luminol (LM) and lucigenin (LC) (Faulkner and 
Fridovich, 1993) and dihydroethidium (DHE) (Zhao et al., 2003b). Using in vitro 
experiments with cultured mammalian or bacterial cells to measure antioxidant 
activity can reflect the real activity of potential antioxidant compounds incorporated 
into the cell. For analysis of reactive oxygen species (ROS), 2´,7´-dichlorofluorescin 
diacetate (DCFH-DA) is widely applied in cell culture. DCFH-DA has been employed 
as a fluorogenic probe and provides a convenient and sensitive way to detect 
intracellular oxidants (Wang and Joseph, 1999; Mody et al., 2001; Girard-Lalancette 
et al., 2009). 
DCFH-DA was first used for measuring hydrogen peroxide levels in a cell free 
system by adding alkali to remove the diacetate moiety (Keston and Brandt, 1965). It 
has been extensively used in the detection of oxidant production during the respiratory 
burst in inflammatory cells, or in cell lysates (Tarpey et al., 2004). Because it is highly 
sensitive to ROS, widely available and easy to use, DCFH-DA has been used as a 
potential probe for studying ROS generation (Hempel et al., 1999; Afzal et al., 2003). 
When non-fluorescent DCFH-DA compounds are taken up by cells, the diacetate 
moiety will be hydrolysed enzymatically by intracellular cellular esterases and 
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converted to non-fluorescent DCFH. The polar DCFH compounds will be retained 
within cells. When oxidants are present, DCFH is oxidized to highly fluorescent 
compounds (DCF) which can be measured with excitation at 485nm and emission at 
538nm. When antioxidant compounds are able to penetrate into the cells and scavenge 
oxidants, the oxidization of the DCFH reaction will be quenched. Therefore, the 
intracellular DCF fluorescence can be used as an index to quantify the cellular 
antioxidant activity (Karadag et al., 2009) (Figure 2.8). 
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Figure 2.8: Schematic of DCFH-DA (Wolfe and Liu, 2007). 
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2.4.1 Cell Culture 
Human hepatocellular carcinoma (Huh7) cells were grown in a growth medium 
(WME supplemented with 5% FBS, 10mM of hepes, 2mM of L-glutamine, 5µg/mL of 
insulin, 0.05µg/mL of hydrocortisone, 50units/mL of penicillin, 50µg/mL 
streptomycin, and 100 µg/mL gentamicin) and were maintained at 37°C and 5% CO2. 
Cells used in this study were between passages 75 to 85. 
2.4.2 Cytotoxicity 
Cytotoxicity was determined by a methylene blue assay. Huh7 cells were seeded 
at 4 × 10
4
 cells/well on a 96-well microplate in 100µL of growth medium and 
incubated for twenty-four hours at 37°C. The medium was removed, and the cells 
were washed with PBS. Treatment of the mushroom extracts or antioxidant 
compounds in 100µL treatment medium (WME supplemented with 2mM L-glutamine 
and 10mM hepes) was applied to the cells, and the plates were incubated at 37°C for 
twenty-four hours. The treatment medium was removed, and the cells were washed 
with PBS. A volume of 50µL/well methylene blue staining solution (98% HBSS, 
0.67% glutaraldehyde, 0.6% methylene blue) was applied to each well, and the plate 
was incubated at 37°C for one hour. The dye was removed, and the plate was 
immersed in deionized water three times, or until the water was clear. The water was 
tapped out of the wells, and the plate was allowed to air-dry briefly before 100µL of 
elution solution (49% PBS, 50% ethanol, 1% acetic acid) was added to each well. The 
microplate was placed on a bench-top shaker for twenty minutes to allow uniform 
elution. The absorbance was measured at 570 nm with blank subtraction using a plate 
reader. 
2.4.3 Cellular antioxidant activity 
The in vitro cellular antioxidant activity assays were based on the method 
described by Wolfe and Liu (2007) with minor modified. Huh7 cells were seeded at a 
density of 6× 10
4
 cells/well on a 96-well microplate in 100µL of growth medium/well. 
The outside wells of the plate were not used as there was much more variation from 
them than from the inner wells. Twenty-four hours after seeding, the growth medium 
was removed and the wells were washed with PBS. Triplicate wells were treated for 
one hour with 100µL mushroom extract plus 25µM 2
´
, 7
´
-dichlroofluoresin diacetate 
(DCFH-DA) dissolved in treatment medium. When a PBS wash was utilized, the  
wells were then washed with 100µL of PBS. Then 1mM of ABAP was applied to the 
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cells in 100µL of HBSS, and the 96-well microplate was placed into a fluorescent 
microplate reader at 37°C. Emission at 538 nm was measured with excitation at 485 
nm every five minutes for one hour. Each plate included triplicate control and blank 
wells; control wells contained cells treated with DCFH-DA and oxidant; blank wells 
contained cells treated with dye and HBSS without oxidant. In each experiment, 
quercetin was used as a standard, and cellular antioxidant activities were expressed as 
micromoles (µmol) of quercetin equivalents (QE) per gram of dried weight (d.w.) 
(Wolfe and Liu, 2007). The quercetin was in serial concentrations of 10, 8, 6, 4, 2 and 
1µmol (Figures 2.9). 
 
Figure 2.9: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells and 
inhibition of oxidation by quercetin. Each value is expressed as mean ± standard 
deviation (n=3 
2.4.4 Quantification of cellular antioxidant activity 
After blank subtraction from the fluorescence readings, the area under the curve 
of fluorescence versus time was integrated to calculate the cellular antioxidant activity 
at each concentration of mushrooms as follows: 
Cellular antioxidant activity unit = × 100 
where ∫SA is the integrated area under the sample fluorescence versus time curve 
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and ∫CA is the integrated area from the control curve (Figure 2.10). 
Figure 2.10: Dose-response curve for the inhibition of peroxyl radical-induced 
DCFH oxidation by quercetin. Each value is expressed as mean ± standard 
deviation (n=3). 
2.5 Statistical analysis 
All the results were presented as means ± standard deviation (SD). Analysis of 
variance was performed on the data taken from triplicates. Differences were detected 
by one-way analysis for variance (ANOVA) followed by multiple comparisons using 
the Fisher least significant difference test. The change in potential antioxidant 
compound release for each mushroom extract during the in vitro enzymatic digestion 
steps was assessed by the differences between ten minutes and ninety minutes of the 
enzymatic incubation step for each sample individually using paired-sample t-tests. 
All data were tested for distribution and if data were not a normal distribution, square 
root data transformation was employed before the correlation test. Correlations were 
obtained by Pearson correlation coefficient. Significance of differences between 
means was determined at the level of 0.05 (p<0.05). All the statistical tests were 
completed using Minitab 16 and Microsoft Excel. 
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Chapter 3 Results 
3.1 Total phenolic contents 
The amount of total phenolic contents, measured by Folin-ciocalteu methods, 
varied widely in mushroom materials and ranged from 203 to 7734µg GAE/g of d.w 
and 126 to 9741µg GAE/g of d.w in hot and cold-water extracts respectively ( see 
Table 3.1). 
In the hot-water extracts, the highest phenolic contents of the medicinal 
mushrooms tested were in C. militaris (7734µg GAE/g of d.w.), followed by G. 
sinense, T. versicolor, P. linteus , Ganoderma amboinense ,G. lucidum, Ganoderma 
atrum, W. extensa (109 ±7µg GAE/g of d.w.) in the hot-water extracts (p< 0.001) (see 
Tables 3.1 and 3.2 and Figure 3.1 ). In the cold-water extracts, the phenolic contents 
of the medicinal mushrooms tested were C. militaris (7313µg GAE/g of d.w.), T. 
versicolor, G. amboinense, G. atrum, G. sinense, G. lucidum, P. linteus, and W. 
extensa (p< 0.001) (Tables 3.1 and 3.2 and Figure 3.1 ). 
In culinary mushrooms, the highest total phenol contents of the hot-water 
extracts of V. volvacea (5082µg GAE/g of d.w) had highest phenolic content, followed 
by Agricus subrufescens, A. cylindracea, and A. bisporus. In the cold-water extracts 
the highest levels of total phenol contents was found in the P. citrinopileatus (9741µg 
GAE/g of d.w), followed by A. bisporus, A. cylindracea and A. subrufescens (p< 
0.001) (Tables 3.1and 3.2 and Figure 3.1). 
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Figure 3.1: Total phenolic compounds assay of hot and cold water extracts. Each value is expressed as mean ± standard deviation (n=3). 
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3.2 Scavenging of 2, 2'-azinobis-(3—ethylbenzothiazoline-6-sulphonate) radical 
cation (ABTS
●+
) 
The ABTS
● +
 free radical scavenging ability of the hot-water extracts ranged 
between 66mmol TE/g of d.w. and 0.67mmol TE/g of d.w., and that of the cold-water 
extracts ranged between 89mmol TE/g of d.w. and 0.2mmol TE/g of d.w. In both the 
hot- and cold-water extracts, the highest ABTS
●+
 free radical scavenging ability was 
found in C. militaris (66 and 89mmol TE/g of d.w. in hot- and cold-water extracts 
respectively, and the lowest ABTS
●+
 free radical scavenging ability was found in W. 
extensa (0.67 and 0.21mmol TE/g of d.w. in hot- and cold-water extracts respectively) 
(p<0.001). (see Tables 3.1 and 3.2, and Figure 3.2 ). The medicinal mushrooms with 
the highest TEAC value in hot-water extracts were C. militaris (66mmol of TE/g of 
d.w.), followed by P. linteus, G. sinense, T. versicolor, G. amboinense, G. lucidum, 
G. atrum , and W. extensa. On the other hand, in the cold-water extracts, the highest 
TEAC value of the medicinal mushrooms was found in C. militaris (89.5mmol of 
TE/g d.w), followed by T. versicolor, G. amboinense, G. atrum, G. sinense, P. 
linteus, G. lucidum and W. extensa. (see Tables 3.1 and 3.2, and Figure 3.2 ). 
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Figure 3.2: TEAC assay of hot- and cold-water mushroom extracts. Each value is expressed as mean ± standard deviation (n=3). 
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A statistically significant relationship was also observed between TEAC and the 
total phenolic contents of the medicinal mushrooms in both hot- and cold-water 
extracts with correlation coefficients equal to 0.937 (p=0.001) and 0.983 (p<0.001) 
respectively (see Figures 3.3 and 3.4). 
Figure 3.3: Correlation between phenolic content and TEAC of hot-water 
extractions of medicinal mushrooms (all data have been square root 
transformed). Each value is expressed as mean (n=3). 
 
 
Figure 3.4: Correlation between phenolic content and TEAC of cold-water 
extractions of medicinal mushrooms (all data have been square root 
transformed). Each value is expressed as mean (n=3). 
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The TEAC value for the culinary mushrooms in hot- and cold-water extractions 
ranged from 60mmol of TE/g d.w. to 1mmol of TE/g d.w. and 81mmol of TE/g d.w. to 
0.2mmol of TE/g d.w. respectively (p<0.001). In hot-water extraction, the culinary 
mushrooms V. volvacea (60 mmol TE/g of d.w.) had highest TEAC value, followed by 
A. subrufescens, A. bisporus, A. cylindracea, P. citrinopileatus and lowest TEAC 
value was found in W. extensa. Whereas, in cold-water extraction, A. bisporus 
(81mmol TE/g of d.w.) had highest TEAC value, followed by A. cylindracea, V. 
volvacea, P. citrinopileatus, and lowest TEAC value was found in W. extensa and 
Tremella funcifromis (0.2mmol TE/g of d.w in both mushrooms). A positive 
relationship between the TEAC values and the phenolic contents of the culinary 
mushrooms was observed with coefficients of 0.861 (p<0.001) and 0.903 (p<0.001) in 
hot-water and cold-water extracts respectively (Figures 3.5and 3.6). 
 
 
 
Figure 3.5: Correlation between phenolic content and TEAC of hot-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
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Figure 3.6: Correlation between phenolic content and TEAC of cold-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
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3. 3 Ferrous reducing power 
The FRAP value of the medicinal mushrooms in hot- and cold-water extraction 
were found within in the range from 14882µmol of Fe
2+
 /g of d.w. to 435µmol Fe
2+
 /g of 
d.w, and 39400µmol Fe
2+
 g of d.w. to 0.463µmol Fe
2+
 /g of d.w respectively (Tables 3.1 
and 3.2 and Figure 3.7) (p<0.001). 
In the hot-water extracts, the highest reducing ability was found in G. sinense 
(14882µmol of Fe
2+
 /g of d.w), followed by C. militaris, G. amboinense, P. linteus, T. 
versicolor, G. atrum, G. lucidum, W. extensa. In the cold-water extraction, C. 
militaris (39400µmol of Fe
2+
 /g of d.w.) had the highest FRAP value, followed by T. 
versicolor, G. amboinense, G. atrum , G sinense, G. lucidum, P. linteus, and W. 
extensa (Table 3.1 and 3.2 and Figure3.7). 
The ferrous reducing antioxidant power (FRAP) of water extracts from the 
selected culinary mushrooms varied from 37196µmol Fe
2+
/g of d.w. to 213µmol Fe
2+
 /g 
of d.w. and 47099µmol Fe
2+
/g of d.w. to 275µmol Fe
2+
/g of d.w. for the hot- and cold-
water extracts respectively. In hot-water extracts of A. bisporus had the highest FRAP 
(37196µmol Fe
2+
 /g of d.w.), followed by A. subrufescens, V. volvacea, and Sarcodon 
imbricatus. The highest FRAP value of the cold-water extracts of the culinary 
mushrooms was found in A. cylindracea with 47099±1757µmol Fe
2+
 /g of d.w., 
followed by P. citrinopileatus, A. subrufescens, and Boletus edulis (p˂0.001) (Tables 
3.1 and 3.2 and Figure 3.7). 
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Figure 3.7: FRAP assay of hot- and cold-water mushroom extracts. Each value is expressed as mean ± standard deviation (n=3). 
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There was no statistically significant correlation between FRAP and total 
phenolic contents of the hot-water extractions of the medicinal mushrooms, for which 
the correlation coefficient was 0.67 (p=0.068) (Figure 3.8), whereas with the 
cold-water extractions, the FRAP value and total phenolic contents showed a 
significant correlation R= 0.98 (p<0.001) (Figure 3.9). 
 
Figure 3.8: Correlation between phenolic content and FRAP of hot-water 
extractions of medicinal mushrooms (the phenolic data have been square root 
transformed). Each value is expressed as mean (n=3). 
 
 
 
 
Figure 3.9: Correlation between phenolic content and FRAP of cold-water 
extractions of medicinal mushrooms (all data have been square root 
transformed). Each value is expressed as mean (n=3). 
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A positive relationship was also found for both the hot- and cold-water extracts 
of the culinary mushrooms (R=0.72, p<0.001 and R= 0.86, p<0.001, respectively) 
(Figures 3.10 and 3.11). 
 
Figure 3.10: Correlation between phenolic content and FRAP of hot-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
 
 
 
Figure 3.11: Correlation between phenolic content and FRAP of cold-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
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3.4 Scavenging effect on 2, 2-diphenylhydrazyl radicals (DPPH) 
The DPPH value of the medicinal mushrooms in hot- and cold-water extractions 
ranged from 4.5mmol TE/g of d.w. to 0.05mmol TE/g of d.w., and from 7.3mmol 
TE/g of d.w. to 0.02mmol TE/g of d.w. respectively. In hot-water extracts, C. militaris 
(4.5mmol TE/g of d.w.) had the highest DPPH values, followed by P. linteus, G. 
sinense, T. versicolor , G. amboinense, G. atrum, G. lucidum), and W. extensa in the 
hot-water extract (p<0.001) (Table 3.1 and 3.2 and Figure 3.12). 
In the cold-water extracts, C. militaris also showed the highest DPPH value 
(7.3mmol TE/g of d.w.), followed by G. atrum, T. versicolor, G. amboinense, G. 
sinense, P. linteus, G. lucidum, and W. extensa (p<0.001) (Table 3.1 and 3.2 and 
Figure 3.12). 
The DPPH values were found in the culinary mushrooms to be between 8.6mmol 
TE/g of d.w. to 0.5mmol TE/g of d.w. and 8.4mmol TE/g of d.w. to 0.18mmol TE/g of 
d.w. in the hot- and cold-water extracts respectively. V. volvacea, A. bisporus, A. 
cylindracea, A. subrufescens, and P. citrinopileatus had high DPPH values among the 
culinary mushrooms in both hot and cold-water extractions (Table 3.1 and 3.2 and 
Figure 3.12). 
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Figure 3.12: DPPH assay of hot and cold mushroom extracts. Each value is expressed as mean ± standard deviation (n=3). 
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A positive relationship between DPPH value and phenolic concentration was 
found in hot- and cold-water extractions with correlation coefficients of 0.94 (p=0.001) 
and 0.95 (p˂0.001) respectively (see Figures 3.13 and 3.14). 
 
Figure 3.13: Correlation between phenolic content and DPPH of hot-water 
extractions of medicinal mushrooms (all data have been square root 
transformed). Each value is expressed as mean (n=3). 
 
 
 
Figure 3.14: Correlation between phenolic content and DPPH of cold-water 
extractions of medicinal mushrooms (all data have been square root 
transformed). Each value is expressed as mean (n=3). 
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With the DPPH method, in the culinary mushrooms, the strong correlation 
between antioxidant activity and total phenolic content was also found in hot-water 
extractions with a correlation coefficient of 0.888 (p<0.001). A positive correlation 
was also found between cold-water extraction and DPPH values, R= 0.903 (p<0.001) 
(see Figures 3.15 and 3.16). 
 
Figure 3.15: Correlation between phenolic content and DPPH of hot-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
 
 
 
Figure 3.16: Correlation between phenolic content and DPPH of cold-water 
extractions of culinary mushrooms (all data have been square root transformed). 
Each value is expressed as mean (n=3). 
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Table 3.1: Hot-water extraction 
Mushroom species Phenolic content 
(µg GAE/g dried 
weight) 
TEAC (mmol TE/g 
dried weight) 
FRAP (µmol Fe
2+/
g 
dried weight) 
DPPH ( mmol TE /g 
dried weight) 
Agaricus bisporus a* 3345±137 50.8±4.3 37196±2218 5.26±0.24 
Agaricus subrufescens b* 3073±39 47.7±3.9 20533±530 3.77±0.14 
Agaricus subrufescens a* 3980±371 55.4±3.1 23822±1884 5.44±0.10 
Agrocybe cylindracea a* 2697±135 34.1±2.9 14377±1192 3.15±0.24 
Agrocybe cylindracea b* 3390±323 49.1±4.7 17176±865 4.20±0.31 
Auricularia auricula-judae e* 203±10 3.6±0.2 984±38 0.53±0.02 
Auricularia auricula-judae b* 218±7 4.2±0.1 1046±46 0.58±0.03 
Boletus edulis e* 2049±80 35.7±2.9 11598.±534 3.38±0.33 
Coprinus comatus b* 2457±74 22.6±1.8 5377±367 1.52±0.10 
Cordyceps militaris d* 7734±342 66.2±5.6 14617±828 4.46±0.31 
Trametes versicolor b* 1441±131 15.5±1.2 7139±160 1.27±0.06 
Ganoderma amboinense d* 753±40 11.3±0.7 13232±494 1.04±0.08 
Ganoderma atrum e* 667±17 7.1±0.30 6589±630 1.02±0.02 
Ganoderma lucidum d* 735±23 9.6±0.57 6254±522 0.88±0.05 
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Ganoderma sinense c* 1478±67 20.9±0.4 14882±702 2.24±0.06 
Grifola frondosa b* 2287±133 19.3±1.0 7073±345 2.09±0.10 
Hericium erinaceus b* 1442±27 10.9±0.5 4616±451 1.85±0.12 
Hericium erinaceus c* 1697±40 10.3±0.8 4576±293 1.52±0.12 
Lentinula edodes b* 1731±46 18.7±1.2 6708±449 2.14±0.11 
Phellinus linteus b* 1154±109 29.2±2.5 9096±347 2.50±0.13 
Pleurotus citrinopileatus b* 2407±86 43.4±2.4 5411±336 4.25±0.15 
Pleurotus citrinopileatus a* 2580±195 40.2±2.4 5734±118 3.20±0.52 
Pleurotus eryngii b* 1021±84 5.4±0.3 1662±82 1.38±0.09 
Pleurotus eryngii a* 1252±89 7.9±0.8 2542±132 1.74±0.06 
Pleurotus ostreatus c* 2316±97 19.1±1.7 3403±395 3.02±0.29 
Wolfiporia extensa c* 109±7 0.67±0.1 435±37 0.05±0.01 
Sarcodon imbricatus e* 2330±138 31.9±1.4 18158 ±1216 3.17±0.05 
Tremella fuciformis b* 321±11 1.4±0.1 213±48 1.01±0.06 
Volvariella volvacea a* 5082±84 60.6±2.7 19913±1268 8.67±0.66 
 
Values are mean ± standard deviation of triplicate analysis (n = 3). p < 0.001 
Origin: a*: Peninsular farm, HK, b*: Nantou, Taiwan, c*: Lianan Yao autonomous county, China, d*: Yen-Ten farm, Chay,I 
Taiwan ,e*:Yunnan,China 
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Table 3.2: Cold-water extraction 
Mushroom species Phenolic content 
(µg GAE/g dried 
weight) 
TEAC (mmol TE/g 
dried weight) 
FRAP (µmol Fe
2+
 /g 
dried weight) 
DPPH (mmol TE/g 
dried weight) 
Agaricus bisporus a* 6998 ±324 81.6 ±7.2 30949±2068 7.15±0.38 
Agaricus subrufescens b* 4548 ±107 38.2 ±1.7 25725±2342 5.11±0.21 
Agaricus subrufescens a* 5830 ±360 62.9 ±3.3 39653±2929 6.44±0.34 
Agrocybe aegerita a* 4926 ±411 51.1 ±1.2 39767±1094 4.81±0.17 
Agrocybe aegerita b* 6335 ±196 68.8 ±5.0 47099±1757 5.80±0.36 
Auricularia auricula-judae e * 290 ±18 4.1 ±0.3 2805±203 0.32±0.01 
Auricularia auricula-judae b* 396 ±18 6.8 ±0.2 3775±159 0.42±0.03 
Boletus edulis e* 4642 ±287 49.4 ±2.9 36213±2001 5.34±0.44 
Coprinus comatus b* 3386 ±138 29.40 ±0.9 22598±1898 2.36±0.21 
Cordyceps militaris d* 7313 ±206 89.53 ±4.2 39400±1009 7.27±0.03 
Trametes versicolor b* 2575 ±128 18.27 ±0.7 13521±689 1.01±0.01 
Ganoderma amboinense d* 1097 ±25 13.34 ±0.3 9589±682 1.00±0.01 
Ganoderma atrum e* 907 ±75.0 9.58 ±0.5 5928±345 1.20±0.06 
Ganoderma lucidum d* 259 ±10.0 2.90 ±0.1 1649±53 0.24±0.01 
Ganoderma sinense c* 712 ±17 8.9 ±0.50 5588±767 0.87±0.06 
101 
 
Grifola frondosa b* 4300 ±45 17.8 ±4.6 14209±1170 2.42±0.1 
Hericium erinaceus b* 2676± 90 17.7 ±1.5 9428±693 3.07±0.16 
Hericium erinaceus c* 2783 ±130 12.7 ±1.1 8319±605 2.49±0.23 
Lentinula edodes b* 4604±289 41.5 ±3.4 18934±1208 5.90±0.69 
Phellinus linteus b* 244 ±5 3.2 ±0.1 1452±114 0.37±0.02 
Pleurotus citrinopileatus 
b
* 8306 ±102 54.6 ±2.7 31040±372 5.74±0.16 
Pleurotus citrinopileatus a* 9741±474 68.3 ±2.9 40537±898 5.62±0.09 
Pleurotus eryngii b* 3044 ±145 11.4 ±0.7 3383±153 1.56±0.16 
Pleurotus eryngii a* 3590 ±208 12.2 ±0.7 4330±459 1.89±0.13 
Pleurotus ostreatus c* 5497 ±193 3.4 ±0.4 5335±494 1.65±0.06 
Wolfiporia extensa c* 126 ±6 0.2 ±0.01 463±12 0.02±0.001 
Sarcodon imbricatus e* 3870 ±197 47.2 ±1.5 21380±1253 5.54±0.05 
Tremella fuciformis b* 250 ±6 0.2 ±0.01 275±26 0.18±0.01 
Volvariella volvacea a* 5226 ±306 68.4 ±3.5 34077±1143 8.46±0.03 
 
Values are mean ± standard deviation of triplicate analysis (n = 3). p < 0.001 
Origin: a*: Peninsular farm, HK, b*: Nantou, Taiwan, c*: Lianan Yao autonomous county, China, d*: Yen-Ten farm, Chay,I 
Taiwan ,e*:Yunnan,China 
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3.5 In vitro enzymatic digestion 
3.5.1 TEAC 
After pepsin digestion, A. auricula-judae, C. militaris, G. lucidum and H. 
erinaceus showed significant decreases (p<0.05) in both the hot- and cold-water 
extracts and P. citrinopileatus had no significant effect (p=0.07 and p=0.059 in the 
hot- and cold-water extracts respectively). T. versicolor showed significant increase 
after pepsin digestion in both the hot- and cold-water extracts (p=0.041 and p=0.047 
in the hot- and cold-water extracts respectively). 
After pancreatin digestion, the ability of ABTS
● +
 radical scavenging was a 
significant increase in A. auricular-judae (p<0.01 in cold extracts), T. versicolor 
(p=0.13 and p< 0.01 in hot- and cold-water extracts respectively), G. lucidum (p=0.04 
and p<0.01 in hot- and cold-water extracts respectively), H. erinaceus (p<0.01 in 
hot-water extracts), and P. citrinopileatus (p<0.01 in both extracts, whereas there was 
no significant different in hot-water extract of A. auricular-judae (p=0.07), hot-water 
extract of C. militaris (p=0.05) and cold-water extract of H. erinaceus (p=0.054) after 
enzymatic digestion. 
In contrast, the potential antioxidant compound release of C. militaris extracts 
showed a decrease in ABTS free radical scavenging ability in cold-water extracts 
(p<0.01) (Figures 3.17 to 3.22 and Table 3.3). 
103 
 
Table 3.3: Total antioxidant activity (mmol TE/g dried weight) of selected 
mushrooms measured by TEAC during the in vitro enzymatic digestion at 10 and 
90 min. Values are means ± SD. Each value is expressed as mean ± standard 
deviation (n=3). 
Mushroom 10 (min) 90 (min) p (10 VS 90) 
Auricularia auricula-judea (Hot water) 4.03±04 5.04±0.21 0.072 
Auricularia auricula-judea (Cold water) 6.63±04 9.70±0.65 0.004 
Cordyceps militaris (Hot water) 66.58±3.6 51.9±3.4 0.050 
Cordyceps militaris (Cold water) 90.23±3.5 65.91±1.5 0.004 
Trametes versicolor (Hot water) 15.09±0.6 22.13±1.4 0.013 
Trametes versicolor (Cold water) 18.04±1.4 33.11±2.3 0.002 
Ganoderma lucidum (Hot water) 9.22±0.3 11.86±1.0 0.041 
Ganoderma lucidum (Cold water) 2.9±0.2 10.95±0.92 0.003 
Hericium erinaceus (Hot water) 11.48±1 14.9±0.64 0.004 
Hericium erinaceus (Cold water) 17.53±0.8 20.59±1.5 0.054 
Pleurotus citrinopileatus (Hot water) 45.27±2 123.56±11.1 0.006 
Pleurotus citrinopileatus (Cold water) 57.77±1.9 102.31±3.6 0.004 
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Figure 3.17: Total antioxidant capacity of A. auricula-judae extracts (hot-water 
and cold-water) measured by using the TEAC assay (mmol Trolox equivalent) 
during the in vitro enzymatic digestion steps. (The symbols *** (p<0.001), ** (p 
<0.01) and * (p <0.05) denote significant differences from the ABTS scavenging 
values prior to the in vitro digestion steps.). Each value is expressed as mean ± 
standard deviation (n=3). 
 
 
 
Figure 3.18: Total antioxidant capacity of C. militaris extracts (hot-water and 
cold-water) measured by TEAC (mmol Trolox equivalents) during the in vitro 
enzymatic digestion steps. The symbols ** (p <0.01) denote significant differences 
from the ABTS scavenging values prior to the in vitro digestion steps.). Each 
value is expressed as mean ± standard deviation (n=3). 
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Figure 3.19: Total antioxidant capacity of T. versicolor extracts (hot-water and 
cold-water) measured by TEAC (mmol Trolox equivalents) during the in vitro 
enzymatic digestion steps. (The symbols *** (p <0.001), ** (p <0.01) and * (p 
<0.05) denote significant differences from the ABTS scavenging values prior to 
the in vitro digestion steps.). Each value is expressed as mean ± standard 
deviation (n=3). 
 
Figure 3.20: Total antioxidant capacity of G. lucidum extracts (hot-water and 
cold-water) measured by TEAC (mmol Trolox equivalents) during the in vitro 
enzymatic digestion steps. The symbols *** (p <0.001), ** (p <0.01) and * (p <0.05) 
denote significant differences from the ABTS scavenging values prior to the in 
vitro digestion steps.). Each value is expressed as mean ± standard deviation 
(n=3). 
106 
 
 
Figure 3.21: Total antioxidant capacity of H. erinaceus extracts (hot-water and 
cold-water) measured by using the TEAC assay (mmol Trolox equivalent) during 
the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * (p <0.05) 
denote significant differences from the ABTS scavenging values prior to the in 
vitro digestion steps.) Each value is expressed as mean ± standard deviation 
(n=3). 
 
 
Figure 3.22: Total antioxidant capacity of P. citrinopileatus extracts (hot-water 
and cold-water) measured using the TEAC assay (mmol Trolox equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * (p 
<0.05) denote significant differences from the ABTS scavenging values prior to 
the in vitro digestion steps.) Each value is expressed as mean ± standard 
deviation (n=3). 
107 
 
Overall, after ninety minutes of in vitro digestion, P. citrinopileatus (123.6 mmol 
TE/g of d.w. in the hot-water extract) showed the highest ATBS free radical 
scavenging ability, followed by P. citrinopileatus (the cold-water extract) > C. 
militaris (the cold-water extract) > C. militaris (the hot-water extract) > T. versicolor 
(the cold-water extract) > T. versicolor (the hot-water extract) > H. erinaceus (the 
cold-water extract) > H. erinaceus (the hot-water extract) > G. lucidum (the hot-water 
extract) > G. lucidum (the cold-water extract) > A. auricula-judae (9 the cold-water 
extract) > A. auricula-judea (the hot-water extract) (p<0.001) (Figure 3.23). 
Figure 3.23: Total antioxidant capacity of selected mushroom extracts (hot-water 
and cold-water) measured by using the (mmol Trolox equivalent) after the in 
vitro enzymatic digestion steps. Bars with different letters are significantly 
different (p < 0.05). Each value is expressed as mean ± standard deviation (n=3). 
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3.5.2 FRAP 
The pattern of potential redox compound release from the six samples during the 
in vitro enzymatic digestion process determined by using the FRAP assay is shown in 
Figures 3.24 to 3.29 and Table 3.4. After pepsin digestion, C. militaris (in both 
extracts) and G. lucidum (in the hot-water extract) showed significant decreases 
(p<0.05), and A. auricula-judae (in the hot-water extract), T. versicolor (in both 
extracts), G. lucidum (in the cold-water extract), H. erinaceus (in both extract) and P. 
citrinopileatus (in both extracts) showed significant increases (p<0.05). The 
cold-water extract of A. auricula-judae showed no significant effect after pepsin 
digestion (p=0.1). 
A. auricula-judae (p<0.01 in both extracts), T. versicolor (p<0.01 in both 
extracts), G. lucidum (p<0.01 in both extracts), H. erinaceus (p<0.01 in both extracts) 
and P. citrinopileatus (p<0.01 in both extracts) all showed significant increases in 
ferric reducing ability after in vitro enzymatic digestion. On the other hand, the 
potential redox compounds release from C. militaris showed significant decreases in 
FRAP value in both extracts (p<0.01 and p˂0.05 in the hot- and cold-water extracts 
respectively) (see Figures 3.24 to 3. 29 and Table 3.4). 
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Table 3.4: Total antioxidant activity (µmol Fe
2+/
g dried weight) of selected 
mushrooms measured by FRAP during the in vitro enzymatic digestion at 10 and 
90 min. Values are means ± SD. Each value is expressed as mean ± standard 
deviation (n=3). 
Mushroom 10 (min) 90 (min) p (10 VS 90) 
Auricularia auricula-judae (Hot water) 1040±100 2784±148 0.003 
Auricularia auricula-judae (Cold water) 3825±198 17229±1280 0.004 
Cordyceps militaris (Hot water) 13818±581 8080±803 0.017 
Cordyceps militaris (Cold water) 37692±762 29950±1201 0.003 
Trametes versicolor (Hot water) 7788±702 82010±5632 0.002 
Trametes versicolor (Cold water) 14465±1287 59218±5875 0.005 
Ganoderma lucidum (Hot water) 5869±459 14469±744 0.004 
Ganoderma lucidum (Cold water) 1559±67 4094±397 0.006 
Hericium erinaceus (Hot water) 4720±360 9090±647 0.007 
Hericium erinaceus (Cold water) 9399±675 17532±1586 0.004 
Pleurotus citrinopileatus (Hot water) 5008±376 15905±868 0.001 
Pleurotus citrinopileatus (Cold water) 30131±2305 54133±2710 0.001 
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Figure 3.24: Total antioxidant capacity of A. auricula-judae extracts (hot-water 
and cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p < 0.01) denote 
significant differences from the FRAP values prior to the in vitro digestion steps.). 
Each value is expressed as mean ± standard deviation (n=3). 
 
 
Figure 3.25: Total antioxidant capacity of C. militaris extracts (hot-water and 
cold-water) measured by FRAP (µmol ferrous ion equivalent) during the in vitro 
enzymatic digestion steps. The symbols *** (p <0.001), ** (p <0.01) and * (p <0.05) 
denote significant differences from the FRAP values prior to the in vitro 
digestion steps.). Each value is expressed as mean ± standard deviation (n=3). 
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Figure 3.26: Total antioxidant capacity of T. versicolor extracts (hot-water and 
cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * (p 
<0.05) denote significant differences from the FRAP values prior to the in vitro 
digestion steps.). Each value is expressed as mean ± standard deviation (n=3). 
 
 
Figure 3.27: Total antioxidant capacity of G. lucidum extracts (hot-water and 
cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * 
(p<0.05) denote significant differences from the FRAP values prior to the in vitro 
digestion steps.) Each value is expressed as mean ± standard deviation (n=3). 
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Figure 3.28: Total antioxidant capacity of H. erinaceus extracts (hot-water and 
cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * (p 
<0.05) denote significant differences from the FRAP values prior to the in vitro 
digestion steps.). Each value is expressed as mean ± standard deviation (n=3). 
 
 
 
Figure 3.29: Total antioxidant capacity of P. citrinopileatus extracts (hot-water 
and cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p <0.01) and * (p 
<0.05) denote significant differences from the FRAP values prior to the in vitro 
digestion steps.) Each value is expressed as mean ± standard deviation (n=3). 
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The hot-water extract of T. versicolor (82010 µmol Fe
2+
/g of d.w.) showed the 
highest redox ability, followed by T. versicolor (the cold-water extract) > P. 
citrinopileatus (the cold-water extract) > C. militaris (the cold-water extract), H. 
erinaceus (the cold-water extract) > A. auricula-judea (the cold-water extract) > P. 
citrinopileatus (the hot-water extract) > G. lucidum (the hot-water extract) > H. 
erinaceus (the hot-water extract) > C. militaris (the hot-water extract) > G. lucidum 
(the cold-water extract) > A. auricula-judea (the hot-water extract) (p<0.001) (Figure 
3.30). 
Figure 3.30: Total antioxidant capacity of selected mushroom extracts (hot-water 
and cold-water) measured by using the FRAP assay (µmol ferrous ion equivalent) 
after the in vitro enzymatic digestion steps. Bars with different letters are 
significantly different (p <0.05). Each value is expressed as mean ± standard 
deviation (n=3). 
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3.5.3 DPPH 
The pattern of potential antioxidant compound release from six mushroom 
samples during in vitro enzymatic digestion determined by using the DPPH assay is 
shown in Figures 3.31 to 3.36 and Table 3.5. After pepsin digestion, C. militaris (in 
both extracts), G. lucidum (in the cold-water extract), H. erinaceus (in both extracts) 
and P. citrinopileatus (in both extracts) showed significant decreases (p<0.05). The 
hot-water extract of G. lucidum and A. auricula-judae (in both extracts) showed no 
significant effect (p=0.5). T. versicolor (in both extracts) showed significant increases 
post-pepsin digestion in both extracts (p<0.05). 
There was a significant increase in the total apparent antioxidant ability on 
scavenging DPPH free radicals for A. auricula-judae (p<0.01 in the hot- and 
cold-water extracts respectively), T. versicolor (p<0.01 in both extracts), G. lucidum 
(p<0.01 and p=0.047 in both extracts), H. erinaceus (p<0.05 in both extracts ), and P. 
citrinopileatus (p<0.01 in both extracts) after the in vitro enzymatic digestion steps. 
The DPPH value of C. militaris showed a significant decrease after the ninety-minute 
digestion step (p< 0.01 in both extracts) (Figures 3.31 to 3.36 and Table 3.5). 
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Table 3.5: Total antioxidant activity (mmol TE/g dried weight) of selected 
mushrooms measured by DPPH during the in vitro enzymatic digestion at 10 and 
90 min. Values are means ± SD. Each value is expressed as mean ± standard 
deviation (n=3). 
Mushroom 
Auricularia auricula-judae (Hot water) 
Auricularia auricula-judae (Cold water) 
Cordyceps militaris (Hot water) 
Cordyceps militaris (Cold water) 
Trametes versicolor (Hot water) 
Trametes versicolor (Cold water) 
Ganoderma lucidum (Hot water) 
Ganoderma lucidum (Cold water) 
Hericium erinaceus (Hot water) 
Hericium erinaceus (Cold water) 
Pleurotus citrinopileatus (Hot water) 
Pleurotus citrinopileatus (Cold water) 
10 (min) 
0.5±0.023 
0.41±0.01 
4.58±0.043 
7.05±0.363 
1.25±0.068 
0.97±0.084 
0.85±0.072 
0.27±0.018 
1.84±0.137 
2.98±0.265 
4.05±0.225 
5.83±0.328 
90 (min) 
2.43±0.115 
1.86±0.104 
1.07±0.044 
5.55±0.280 
4.01±0.178 
1.96±0.103 
1.57±0.066 
0.33±0.005 
2.15±0.137 
3.36±0.199 
6.89±0.378 
8.84±0.504 
 p (10 VS 90) 
0.001 
0.001 
 ˂0.001 
0.005 
0.001 
 ˂0.001 
0.004 
0.047 
0.016 
0.034 
0.001 
0.002 
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Figure 3.31: Total antioxidant capacity of A. auricula-judae extracts (hot-water 
and cold-water) measured by using the DPPH assay (mmol Trolox equivalent) 
during the in vitro enzymatic digestion steps. The symbols ** (p < 0.01) and * (p< 
0.05) denote significant differences from the DPPH scavenging values prior to the 
in vitro digestion steps). Each value is expressed as mean ± standard deviation 
(n=3). 
 
 
 
Figure 3.32: Total antioxidant capacity of C. militaris extracts (hot-water and 
cold-water) measured by using the DPPH assay (mmol Trolox equivalent) during 
the in vitro enzymatic digestion steps. The symbols *** (p < 0.001), ** (p < 0.01) 
and * (p < 0.05) denote significant differences from the DPPH scavenging values 
prior to the in vitro digestion steps). Each value is expressed as mean ± standard  
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deviation (n=3). 
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Figure 3.33: Total antioxidant capacity of T. versicolor extracts (hot-water and 
cold-water) measured by using the DPPH assay (mmol Trolox equivalent) during 
the in vitro enzymatic digestion steps. The symbols *** (p< 0.001), ** (p < 0.01) 
and * (p < 0.05) denote significant differences from the DPPH scavenging values 
prior to the in vitro digestion steps). Each value is expressed as mean ± standard 
deviation (n=3). 
 
 
Figure 3.34: Total antioxidant capacity of G. lucidum extracts (hot-water and 
cold-water) measured by using the DPPH assay (mmol Trolox equivalent) during 
the in vitro enzymatic digestion steps. The symbols ** (p < 0.01) and * (p < 0.05) 
denote significant differences from the DPPH scavenging values prior to the in 
vitro digestion steps). Each value is expressed as mean ± standard deviation 
(n=3). 
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Figure 3.35: Total antioxidant capacity of H. erinaceus extracts (hot-water and 
cold-water) by using the DPPH assay (mmol Trolox equivalent) during the in 
vitro enzymatic digestion steps. The symbols *** (p < 0.001), ** (p < 0.01) and * 
(p < 0.05) denote significant differences from the DPPH scavenging values prior 
to the in vitro digestion steps). Each value is expressed as mean ± standard 
deviation (n=3). 
 
 
Figure 3.36: Total antioxidant capacity of P. citrinopileatus extract (hot-water and 
cold-water) measured by using the DPPH assay (mmol Trolox equivalent) during 
the in vitro enzymatic digestion steps. The symbols *** (p < 0.001), ** (p < 0.01) 
and * (p < 0.05) denote significant differences from the DPPH scavenging values 
prior to the in vitro digestion steps). Each value is expressed as mean ± standard 
deviation (n=3). 
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Overall, after ninety minutes of in vitro digestion, P. citrinopileatus (8.8mmol 
TE/g of d.w. in the cold-water extract) showed the highest DPPH free radical 
scavenging ability, followed by P. citrinopileatus (the hot-water extract) > C. militaris 
(the cold-water extract) > T. versicolor (the hot-water extract) > H. erinaceus (the 
cold-water extract) > A. auricula-judae (the hot-water extract) > H. erianceus (the 
hot-water extracts) > T. versicolor (the cold-water extract) > A. auricula-judae (the 
cold-water extract) > G. lucidum (the hot-water extract) > C. militaris (the hot-water 
extract) > G. lucidum (the cold-water extract) (p < 0.001) (Figure 3.37). 
Figure 3.37: Total antioxidant capacity of selected mushroom extracts (hot-water 
and cold-water) measured by using the DPPH assay (mmol Trolox equivalent) 
after the in vitro enzymatic digestion steps. Bars with different letters are 
significantly different (p < 0.05). Each value is expressed as mean ± standard 
deviation (n=3). 
 
 121 
3.6 Cytotoxicity 
Concentrations of mushroom extracts which decreased the absorbance by > 10% 
when compared with the control were considered to be cytotoxic. According to the 
cytotoxicity assay (see Figures 3.38 to 3.49), the dosages of each mushroom extract 
for cellular antioxidant assay were: A. auricula-judae 1 mg /ml for both hot- and 
cold-water extracts, C. militaris 0.25 mg/ml and 0.6 mg/ml for hot- and cold-water 
extracts respectively, T. versicolor 0.5 mg/ml for both hot- and cold-water extracts, G. 
lucidum 0.48 mg/ml and 0.5 mg/ml for hot- and cold-water extracts respectively, H. 
erinaceus 5 mg/ml and 4 mg/ml for hot- and cold-water extracts respectively, and P. 
citrinopileatus 1.5 mg/ml and 2 mg/ml for hot- and cold-water extracts respectively. 
 
Figure 3.38: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of A. auricula-judae. Each value is expressed as mean ± 
standard deviation (n=3). 
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Figure 3.39: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of A. auricula-judae. Each value is expressed as mean ± 
standard deviation (n=3). 
 
 
Figure 3.40: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of C. militaris. Each value is expressed as mean ± standard 
deviation (n=3). 
 123 
Figure 3.41: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of C. militaris. Each value is expressed as mean ± standard 
deviation (n=3). 
Figure 3.42: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of T. versicolor. Each value is expressed as mean ± standard 
deviation (n=3). 
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Figure 3.43: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of T. versicolor. Each value is expressed as mean ± standard 
deviation (n=3). 
Figure 3.44: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of G. lucidum. Each value is expressed as mean ± standard 
deviation (n=3). 
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Figure 3.45: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of G. lucidum. Each value is expressed as mean ± standard 
deviation (n=3). 
Figure 3.46: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of H. erinaceus. Each value is expressed as mean ± standard 
deviation (n=3). 
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Figure 3.47: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of H. erinaceus. Each value is expressed as mean ± standard 
deviation (n=3). 
Figure 3.48: Cell survivals of Huh7 cells treated with various concentrations of 
hot-water extract of P. citrinopileatus. Each value is expressed as mean ± 
standard deviation (n=3). 
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Figure 3.49: Cell survivals of Huh7 cells treated with various concentrations of 
cold-water extract of P. citrinopileatus. Each value is expressed as mean ± 
standard deviation (n=3). 
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3.7 Cellular antioxidant activity 
The cellular antioxidant activity for the mushrooms ranged from 3557µmol QE/g 
of d.w. to 68µmol QE/g d.w. The cellular antioxidant activity values are shown in 
Table 3.5. 
Table 3.5: Antioxidant capacity (µmol QE/g dried weight) of selected mushrooms 
using the cellular antioxidant activity assay. Each value is expressed as mean ± 
standard deviation (mean ± SD, n=3). 
Mushroom Cellular antioxidant activity (µmol QE/g) 
Auricularia auricula-judae (Hot water) 126±4 
Auricularia auricula-judae (Cold water) 236±26 
Cordyceps militaris (Hot water) 2638±247 
Cordyceps militaris (Cold water) 3557±305 
Trametes versicolor (Hot water) 735±80 
Trametes versicolor (Cold water) 550±41 
Ganoderma lucidum (Hot water) 278±21 
Ganoderma lucidum (Cold water) 107±12 
Hericium erinaceus (Hot water) 68±6 
Hericium erinaceus (Cold water) 106±10 
Pleurotus citrinopileatus (Hot water) 192±20 
Pleurotus citrinopileatus (Cold water) 340±20 
 
In this study, 2´, 7´-dichlorofluorescin diacetate was taken up by Huh7 cells by 
passive diffusion and deactylated by cellular esterases to form polar 2 ´, 
7´-dichlorofluorescin (DCFH), which is trapped within the cells. All of six selected 
mushrooms showed varying degrees of quenching ability of peroxyl radicals. C. 
militaris, a traditional medicinal mushroom, had a significantly higher antioxidant 
activity value than the other mushrooms (p<0.001) (Figure 3.50 to Figure 3.61). 
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Figure 3.50: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by A. acuriculla-judae hot water extracts. Each value 
is expressed as mean ± standard deviation (mean ± SD, n=3). 
 
 
Figure 3.51: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by A. acuriculla-judae cold water extracts. Each value 
is expressed as mean ± standard deviation (mean ± SD, n=3). 
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Figure 3.52: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by C. militari hot water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 
Figure 3.53: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by C. militari cold water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
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Figure 3.54: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by 1. versicolor hot water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 
Figure 3.55: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by 1. versicolor cold water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
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Figure 3.56: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by G. lucidum hot water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 
Figure 3.57: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by G. lucidum cold water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
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Figure 3.58: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by H. erinaceus hot water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 
 
Figure 3.59: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by H. erinaceus cold water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 134 
 
Figure 3.60: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by P. citrinopileatus hot water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 
 
Figure 3.61: Peroxyl radical-induced oxidation of DCFH to DCF in Huh7 cells 
and inhibition of oxidation by P. citrinopileatus cold water extracts. Each value is 
expressed as mean ± standard deviation (mean ± SD, n=3). 
 135 
After sixty minutes of incubation, the highest cellular antioxidant activity values 
was C. militaris in both the hot- and cold-water extracts, followed by T. versicolor (in 
both extracts, the cold-water extract of P. citrinopileatus, the hot-water extract of G. 
lucidum, the cold-water extract of A. auricula-judae, the hot-water extract of P. 
citrinopileatus, the hot-water extract of A. auricula-judae, the cold-water extract of G. 
lucidum, and the cold-water extract of H. erinaceus, and the hot-water extract of H. 
erinaceus (p<0.05) (see Figure 3.62). 
Figure 3.62: Cellular antioxidant activity of selected mushroom extracts after 
sixty-minute measurement. Bars with different letters are significantly different 
(p < 0.05). Each value is expressed as mean ± standard deviation (mean ± SD, 
n=3). 
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3.7 Correlation Analysis 
The relationships in cellular antioxidant activity value between total phenolic 
contents, TEAC, FRAP, and DPPH were determined. The correlation coefficient for 
cellular antioxidant activity and total phenolic content of the hot-water extracts of 
selected mushrooms was significant at 0.94 (p˂0.01). In contrast, the cellular 
antioxidant activity of the cold-water extracts of mushrooms was not significantly 
correlated to total phenolic content; the correlation coefficient was 0.56 (p=0.25) 
(Figure 3.63 and 3.64). 
 
Figure 3.63: Correlation between total phenolic content and cellular antioxidant 
activity of hot-water extracts. Each value is expressed as mean (n=3). 
 
 
 
Figure 3.64: Correlation between total phenolic content and cellular antioxidant 
activity of cold-water extracts. Each value is expressed as mean (n=3). 
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The cellular antioxidant activity of the hot-water mushroom extracts was 
positively correlated with FRAP, and of the cold-water extracts was positively 
correlated with TEAC, whereas the antioxidant values of other chemical reactions for 
the mushrooms in both hot- and cold-water extracts were not significantly positively 
related to cellular antioxidant activity. Compared with the chemical-based antioxidant 
assays, total phenolic contents, TEAC, FRAP and DPPH, the correlation coefficients 
for the cellular antioxidant activity values of hot- and cold-water extracts and TEAC 
were 0.8 (p=0.054) and 0.86 (p<0.05) respectively (Figure 3.65 and 3.66). 
Figure 3.65: Correlation between TEAC and cellular antioxidant activity of 
hot-water extracts. Each value is expressed as mean (n=3). 
 
 
 
Figure 3.66: Correlation between TEAC and cellular antioxidant activity of 
cold-water extracts. Each value is expressed as mean (n=3) 
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The correlation coefficients for the cellular antioxidant activity values of hot- and 
cold-water extracts and FRAP were 0.93 (p˂0.05) and 0.76 (p=0.079) respectively 
(Figure 3.67 and 3.68). 
 
Figure 3.67: Correlation between FRAP and cellular antioxidant activity of hot 
-water extracts. Each value is expressed as mean (n=3). 
 
 
 
Figure 3.68: Correlation between FRAP and cellular antioxidant activity of 
cold-water extracts. Each value is expressed as mean (n=3). 
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The correlation coefficients for the cellular antioxidant activity values of hot- and 
cold-water extracts and DPPH were 0.56 (p=0.25) and 0.71(p=0.11) respectively 
(Figure 3.69 and 3.70). 
Figure 3.69: Correlation between DPPH and cellular antioxidant activity of 
hot-water extracts (DPPH value have been square root transformed). Each value 
is expressed as mean (n=3). 
 
 
Figure 3.70: Correlation between DPPH and cellular antioxidant activity of 
cold-water extracts. Each value is expressed as mean (n=3). 
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Chapter 4 Discussion 
4.1 Total phenolic contents 
Mushrooms develop an analogous defence mechanism to those in plants against 
insects and micro-organisms by mechanisms such as the production of phenolic 
compounds (Vaz et al., 2011). For instance, melanins are phenolic compounds present 
in many mushrooms and it has been suggested that they are involved in the defence 
against pathogens (Islas-Flores et al., 2006; Berendsen et al., 2010). Alcalinaphenol A 
is a fungicide isolated from Mycena alcalina and is able to prevent other species from 
growing in the surrounding area (Spiteller, 2008). Moreover, in wound-activated 
chemical defence, mushrooms have developed different unique wound-activated 
chemical defence reactions involving the oxidation of phenols, such as 
2-chloro-4nitro-phenol in Stephanospora caroticolor (Spiteller, 2008). 
In this study, both hot- and cold-water mushroom extracts showed antioxidant 
activity, however, the magnitude of antioxidant potency varied with the type of extract. 
This could be due to the differences in concentrations and types of antioxidant 
compound present in the extracts. Overall, the amounts of phenolic contents extracted 
from the culinary mushrooms were higher than those from the medicinal mushrooms. 
The total average concentration of phenolic compounds in hot-water extraction was 
2184µg of GAE/g and 1758µg of GAE/g and the total average in cold-water extracts 
was 4344µg of GAE/g and 1653µg of GAE/g in culinary and medicinal mushrooms 
respectively. A study of 39 medicinal and culinary herbs by Zheng and Wang (2001) 
also reported that culinary herbs had much higher total phenolic contents than 
medicinal herbs (Zheng and Wang, 2001; Kim et al., 2008). However, comparing 
edible mushrooms with medicinal mushrooms, which were cultivated mushrooms 
from Korea, Kim et al. (2008) reported that the total phenolic content of the medicinal 
mushrooms was higher than that of the edible mushrooms. 
Generally, in this current study, the cold-water extracts showed more 
polyphenolic compounds than the hot-water extracts, whereas the hot-water extracts 
of C. militartis, G. sinense, P. linteus and T. fuciformis had more phenolic compounds 
than the cold-water extracts. Lee (2007b) reported similar findings that cold-water 
extracts of H. marmoreus had more polyphenolic compounds than hot-water extracts 
(Lee et al., 2007b). Yeh et al. (2011) also reported that cold-water extracts of G. 
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frondosa had more phenolic compounds than hot-water extracts (Yeh et al., 2011). A 
similar result was found in this current study. A similar result was also found in tea 
pollen extracts: a study of Camellia sinensis indicated that the cold-water extracts had 
higher flavonoid contents than hot-water extracts (Kao et al., 2011). In this current 
study, the cold-water extracts of Pleurotus spp. had higher phenolic contents than the 
hot-water extracts. Similar results were found in Pleurotus sajor-caju and Pleurotus 
florida by Shinde and Deshmukh (2012). In a study of P. citrinopileatus, Lee et al. 
(2007a) reported that hot-water extracts had higher phenolic contents than cold-water 
extracts. However, in this current study the cold-water extracts of P. citrinopileatus 
had higher phenolic contents than the hot-water extracts. A study of hot-water 
mushroom extracts reported that the level of phenolic contents was G. lucidum > 
Agrocybe spp. > P. eryngii > V. volvaceae > L. edodes > H. erinaceus > A. 
auricular-judae (Abdullah et al., 2011). In this current study the phenolic contents of 
hot-water extracts was V. volvaceae > A. cylindracea (Hong Kong and Taiwan) > L. 
edodes > H. erinaceus (China and Taiwan) > P. eryngii (Hong Kong and Taiwan) > G. 
lucidum > A. auricular-judae (China and Taiwan). The phenolic contents of 
cold-water extracts was A. cylindracea (Hong Kong) > V. volvaceae > A. cylindracea 
(Taiwan) > L. edodes > P. eryngii (Hong Kong and Taiwan) > H. erinaceus (China 
and Taiwan) > G. lucidum > A. auricular-judae (China and Taiwan). Tsai et al. (2007) 
reported that the phenolic contents of hot-water extracts of A. subrufescens, A. 
cylindracea and B. edulis had no significant difference (Tsai et al., 2007). In this 
current study, the phenolic contents of hot-water extracts were that A. subrufescens 
(Nantou, Taiwan) had higher total phenolic contents and there was no significant 
difference between A. subrufescens (Hong Kong) and A. cylindracea (Hong Kong and 
Taiwan), whereas B. edulis had the lowest phenolic contents compared with A. 
subrufescens and A. cylindracea. In cold-water extracts, the phenolic contents of A. 
subrufescens (Taiwan) and A. cylindracea (Taiwan) had no significant differences, 
and also had higher phenolic contents than A. subrufescens (Hong Kong), A. 
cylindracea (Hong Kong) and B. edulis. There was no statistical difference between A. 
subrufescens (Hong Kong), A. cylindracea (Hong Kong) and B. edulis, which is 
similar to the results which Tsai et al. (2007) reported. In this current study, the 
phenolic content of hot-water extracts of Coprinus comatus was 2457µg GAE/g, 
however, Tsai et al. (2009) reported a finding of 5600µg GAE/g (Tsai et al., 2009). A 
study of metholic extracts reported that T. versicolor had 2328µg GAE/g (Mau et al., 
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2002). In this current study, the water extracts of T. versicolor were 1441 and 2575µg 
GAE/g in hot- and cold-water extracts respectively. Barros et al. (2007c) reported that 
the methanolic extract of Scardon imbricatus was 3760µg GAE/g (Barros et al., 
2007c). In this current study, the hot- and cold-water extracts of S. imbricatus were 
2330 and 3870µg GAE/g respectively. Mau et al. (2002) demonstrated that the 
methanolic extract of H. erinaceus was 120µg GAE/g (Mau et al., 2002). As results 
presented in Chapter 2 show, the amounts of the hot- and cold-water extracts of H. 
erinaceus (China and Taiwan) were 1442 and 1697µg GAE/g and 2676 and 2783µg 
GAE/g respectively. Lee et al. (2007a) demonstrated that the amount of phenolic 
compounds in hot-water extracts of P. citrinopileatus was higher than that of 
cold-water extracts. In this current study, the amount of phenolic compounds of the 
cold-water extract of P. citrinopileatus was higher than that of hot-water extracts. 
Samchai et al. (2009) reported that the cold-water extract of P. linteus was 596µg 
GAE/g (Samchai et al., 2009). In this current study, the hot- and cold-water extracts of 
P. linteus were 1154 and 244µg GAE/g respectively. Cheung et al. (2003) reported 
that the phenolic contents of water extracts of L. edodes and V. volvacea were 1330 
and 1340µg GAE/g respectively (Cheung et al., 2003). In this current study, the 
phenolic contents of L. edodes were 1731 and 4604µg GAE/g in hot- and cold-water 
extracts respectively, and of V. volvacea were 5082 and 5226µg GAE/g in hot- and 
cold-water extracts respectively. Mau et al. (2001) reported that the amount of 
phenolic content of methanolic extracts of T. fuciformis was 1040 µg GAE/g; however, 
in this current study, the phenolic contents of hot- and cold-water extracts were 321 
and 250µg GAE/g respectively. 
FRAP 
C. militaris, G. amboinese and G. sinense showed higher ferric reducing values 
than the other medicinal mushrooms used in this study. The hot-water extracts of 
Ganoderma spp., P. linteus and W. extensa had higher FRAP values than the 
cold-water extracts. In the culinary mushrooms, the hot-water extracts of A. bisporus 
and V. volvacea had higher FRAP values than the cold-water extracts. In a study of the 
leaf of Melissa officinalis L., Katalinic et al. (2006) pointed out that M. folium leaf 
infusions with hot (98°C) and cold (20°C) water could both release antioxidants and 
that preparations at higher temperature released more than twice the antioxidant 
capacity determined by FRAP (Katalinic et al., 2006). From a study of the seeds of 
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Lablab purpureus (L.) Sweet, Vijayakumari et al. (1995) suggested that a certain 
amount of polyphenols may react with other components to form an insoluble 
complex or may be oxidized during a long period of time of soaking at a higher 
temperature (Vijayakumari et al., 1995). 
However, the opposite observation was found in C. militaris, T. versicolor and 
other selected mushrooms whose cold-water extractions had higher ferric reducing 
power than hot-water extractions. Similarly, a study of the fungus Monascus spp. 
found that cold-water extracts had higher reducing power than hot-water extracts (Lee 
et al., 2008). Lee et al. (2008) suggested that heating might cause thermal damage to 
certain reducing components (Lee et al., 2008). Lee et al. (2007a); Lee et al. (2007b) 
reported that cold-water extracts of H. marmoreus and P. citrinopileatus exhibited 
higher reducing power than their hot-water extracts (Lee et al., 2007a; Lee et al., 
2007b). In this current study, the cold-water extracts of P. citrinopileatus showed 
higher FRAP value than the hot-water extracts. 
In studies of hot-water extracts, B. edulis had higher reducing power than P. 
citrinopileatus > A. cylindracea > A. subrufescens > C. comatus (Tsai et al., 2007; 
Tsai et al., 2009). In this current study, the hot-water extracts of A. subrufescens 
(Hong Kong and Taiwan) had higher reducing power than those of A. cylindracea 
(Hong Kong and Taiwan) > A. cylindracea (Hong Kong and Taiwan) >P. 
citrinopileatus (Hong Kong and Taiwan) > B. edulis > C. comatus. In the cold-water 
extracts, A. cylindracea (Hong Kong and Taiwan) had higher reducing power than A. 
subrufescens (Hong Kong and Taiwan) > P. citrinopileatus (Hong Kong) > B. edulis > 
P. citrinopileatus (Taiwan) > C. comatus. In a study of Turkish wild mushrooms, the 
order of FRAP values was B. badius > A. bisporus > P. ostreatus (Elmastas et al., 
2007). In this current study, the hot-water extract of A. bisporus showed the highest 
FRAP value, followed by B. edulis ˃ P. ostreatus, and the cold-water extracts 
showed a similar order (B. edulis > A. bisporus > P. ostreatus). 
DPPH 
Compared with published reports of P. citrinopileatus in which cold-water 
extracts had higher DPPH scavenging ability than hot-water extracts, in this current 
study, the cold-water extract of P. citrinopileatus had higher DPPH scavenging value 
than the hot-water extract (Lee et al., 2007a). Another study of hot- and cold-water 
144 
 
extracts of Pleurotus spp. also reported that cold-water extracts exhibited higher 
antioxidant activity than hot-water extracts (Shinde and Deshmukh, 2012). 
The same finding was made in the cold-water extracts of Hypsizigus marmoreus 
which had been reported to have had higher DPPH value than hot-water extracts (Lee 
et al., 2007b). Also, in a study of V. volvacea and L. edodes, the aqueous extract of V. 
volvacea showed higher DPPH scavenging ability than that of L. edodes, and in this 
current study similar results were observed (Cheung et al., 2003; Abdullah et al., 
2011). Different authors have reported different DPPH values. In a study of 
methanolic extracts of A. bisporus, Savoie et al. (2008) reported that the DPPH value 
of strain X25, Bs0633 and Bs0118 were 4.97, 3.47 and 3.33mg/ml respectively. 
However, (Barros et al., 2009) reported that the DPPH value of methanolic extracts of 
A. bisporus was 9.61mg/ml. (Barros et al., 2007a; Barros et al., 2009). According to 
published data, S. imbricatus (methanolic extracts) (Barros et al., 2007c) had the most 
efficient DPPH radical scavenging ability, followed by A. bisporus (brown) (Barros et 
al., 2008) > A. bisporus (Reis et al., 2012) > A. bisporus (young) (Soares et al., 2009) 
> A. bisporus (mature) (Soares et al., 2009) > A. bisporus (Bs0118H)(Savoie et al., 
2008) > A. bisporus (Bs0633) (Savoie et al., 2008) > G. frondosa (Mau et al., 2004) > 
A. bisporus (x25) (Savoie et al., 2008) > G. lucidum(Abdullah et al., 2011) > S. 
imbricatus (Barros et al., 2009) > L. edodes (Reis et al., 2012) > P. ostreatus (Reis et 
al., 2012) > P. eryngii (Reis et al., 2012) > A. bisporus (Barros et al., 2009) > A. 
subrufescens (Tsai et al., 2007) > P. citrinopileatus (Lee et al., 2007a) > P. 
citrinopileatus (Abdullah et al., 2011) > B. edulis (Tsai et al., 2007) > P. 
citrinopileatus (Lee et al., 2007a) > V. volvacea (Abdullah et al., 2011) > A. 
auricula-judae (Abdullah et al., 2011) > A. cylindracea (Tsai et al., 2007). In the 
results of the current study, the hot-water extracts of V. volvacea had the highest 
DPPH value > A. bisporus > A. subrufescens (Hong Kong) > L. edodes > A. 
cylindracea (Taiwan)> P. citrinopileatus (Taiwan) > P. citrinopileatus (Hong Kong) > 
S. imbricatus > B. edulis > A. subrufescens (Taiwan) > A. cylindracea (Hong Kong) > 
H. erinaceus (Taiwan) > H. erinaceus (China) > P. eryngii (Taiwan) > P. eryngii 
(Hong Kong) > P. ostreatus > A. auricula-judae (Taiwan) > A. auricula-judae (China) 
> G. lucidum. In the cold-water extracts, V. volvacea also had highest the DPPH value 
> A. bisporus > A. subrufescens (Hong Kong) > A. cylindracea (Taiwan)> P. 
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citrinopileatus (Taiwan) > P. citrinopileatus (Hong Kong) > L. edodes > S. imbricatus 
> A. subrufescens (Taiwan) > H. erinaceus (Taiwan) > H. erinaceus (China) > G. 
frondosa > > P. eryngii (Hong Kong) > P. eryngii (Taiwan) > P. ostreatus > A. 
auricula-judae (Taiwan) > A. auricula-judae (China). 
TEAC 
There are only a few published TEAC data on mushroom extracts. According to 
the published data, A. bisporus Bs0118H strain had the highest ABTS free radical 
scavenging ability followed by Bs036 strain > X25 strain > V. volvacea > L. edodes 
(Cheung et al., 2003; Savoie et al., 2008). In this current study, the same order was 
found in both hot- and cold-water extracts. Also, in this current study, hot-water 
extracts of the medicinal mushroom P. linteus showed higher antioxidant activity than 
G. lucidum and in the TEAC, FRAP and DPPH assays the results were similar to 
those of Lakshmi (Lakshmi et al., 2004). Instead of using hydrogen peroxide to 
generate ABTS
●+
 free radicals, in this current study the ABTS
●+
 was generated by 
using potassium persulfate, which gives higher sensitivity (Re et al., 1999). The 
hot-water extracts of A. subrufescens (Taiwan), G. lucidum, G. sinense, G. frondosa, L. 
edodes, P. ostreatus, W. extensa and T. fuciformis had higher TEAC values than the 
cold-water extracts, whereas the cold-water extracts of other mushrooms had higher 
values than the hot-water extracts. In their study of Pleurotus spp. Shinde and 
Deshmukh (2012) reported that the cold-water extracts had higher TEAC values than 
the hot-water extracts. Lee et al. (2007b) suggested that hot water might cause the 
thermal destruction of some antioxidant components. Due to the fat-soluble nature of 
β-carotene and tocopherols, Lee et al. (2007b) postulated that the naturally occurring 
antioxidants found in mushroom water extracts were ascorbic acid and phenols, and 
the ascorbic acid and phenol contents of H. marmoreus cold-water extracts were 
higher than those of hot-water extracts (Lee et al., 2007b). 
The influence of heat processing on the antioxidant ability of edible mushrooms 
has already been reported. A study of L. edodes has shown that the concentration of 
phenolic content and antioxidant properties could be increased by cooking (Choi et al., 
2006). On the other hand, some authors have reported that thermally-processed 
mushroom showed lower phenolic contents than a raw sample (Manzi et al., 2004; 
Barros et al., 2007a). 
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Typical phenolics that possess antioxidant activity are known to be mainly 
phenolic acids and flavonoids. Many studies have expected that herbal extracts would 
possess antioxidant properties because they are rich sources of phenolic compounds 
(Zheng and Wang, 2001; Wojdylo et al., 2007). It has been suggested that strains, 
period of mushroom harvest and shelf life cause the variations in the antioxidant 
properties of mushrooms. Ribeiro et al. (2007) suggested that the stability of phenol 
contents may be affected by the time since collection, which is suggested to be due to 
enzymatic and oxidative decomposition together with the different stress conditions to 
which mushrooms are subjected, as well as the different extraction methodologies, in 
addition to possible genetic variabilities. Savoie et al. (2008) demonstrated that there 
was different antioxidant activity between different A. bisporus strains. Savoie et al. 
(2008) reported that the EC50 of reducing power of methanolic extracts of A. bisporus 
strains (X25, Bs036 and Bs0118H) were 3.37, 3.11 and 1.76mg/mL with phenolic 
contents 31, 49 and 40mg of GAE/g respectively. Another study of methanolic 
extracts carried out by Barros et al. (2008) reported that the EC50 of reducing power of A. 
bisporus was 3.63 mg/ml with phenolic contents 4.5mg of GAE/g (Barros et al., 
2008). 
Moreover, different authors reported different results. In studies of L. edodes, 
Cheoung (2003), Yang (2002) and Choi (2006) reported phenolic contents of 1330µg 
of GAE/g, 3800µg of GAE/g and 6300µg of GAE/g respectively, whereas in this 
current study, the total phenolic contents of L. edodes were 1700 and 4600µg of 
GAE/g in the hot- and cold-water extracts respectively (Yang et al., 2002; Cheung et 
al., 2003; Choi et al., 2006). 
In addition, studies of P. ostreatus have also reported varying phenolic content 
values: Fu (2002) reported 390µg of GAE/g and Elmastas (2007) reported 12100µg of 
GAE/g, whereas the phenolic value of P. ostreatus reported by Jayakumar (2009) was 
5490µg of GAE/g. Similar values were found in this current study: the value of total 
phenolic content found in the cold-water extract of P. ostreatus was 5497µg of GAE/g, 
whereas that in the hot-water extract contained 2300µg of GAE/ g (Fu et al., 2002; 
Elmastas et al., 2007; Jayakumar et al., 2009). 
A report on Russula delica, a mushroom collected from Portugal and Turkey, 
showed different phenolic profiles and in a study of Fistulina hepatica, different 
authors produced different results of phenolic content even with samples collected 
from the same region (Ribeiro et al., 2007; Yaltirak et al., 2009; Vaz et al., 2011). 
In addition, in a study of the phenolic content and antioxidant activity of 
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vegetables, the measurement values of red beetroot were conflicting in a number of 
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reports. The measurement values of Stratil et al. (2006) were five times higher than 
those reported by Kähkönen (1999), but 20% lower than those of Vinson et al (2001) 
(Kähkönen et al., 1999; Vinson et al., 2001; Imeh and Khokhar, 2002; Stratil et al., 
2006). Moreover, conflicting results have also been found in strawberries. In various 
studies of strawberries, different authors have found different results for the phenolic 
contents. The amount of phenolic content found by Proteggente (2002) was 3300µg of 
GAE/g whereas Heinonen (1998) found that the phenolic contents of strawberries was 
16100µg of GAE/g (Heinonen et al., 1998; Proteggente et al., 2002). 
Therefore, the amount of polyphenols and antioxidant capacity also depended on 
the method of extraction, and the deviations among the results from hot- and cold- 
water extraction can be explained by the fact that the content of phenolic compounds 
in some species of mushroom can be influenced. Lee et al. (2003) demonstrated that 
simple heat treatment on rice hull extracts could not cleave covalently bound phenolic 
compounds from rice hull. Jeong et al. (2004) suggested that the phenolic compounds 
of plants should be present in different bound statuses depending on species. Thus, 
effective processing steps for liberating phenolic compounds from various samples 
may be different (Jeong et al., 2004). There are various internal and external factors 
that might possibly influence the total phenolic contents in the presented results of 
observed antioxidant effects, for instance, agrotechnical processes, cultivars, soil 
composition, climate, geographic origin, and/or exposure to disease prevailing during 
growth (Manach et al., 2004; Schaffer et al., 2005; Stratil et al., 2006). It had been 
reported that the ability of an individual mushroom species to grow and fruit using 
different substrates is largely dependent on the ability of the fungus to use the major 
components of the substrates as a nutritional source (Buswell et al., 1993). 
Shashirekha et al. (2005) suggested that the biomass produced as mushroom fruiting 
bodies shows clear chemical differences from different substrates. 
Published data have reported the free radical scavenging ability as the efficient 
concentration (EC50) (Fu et al., 2002; Yang et al., 2002; Cheung et al., 2003; Lakshmi 
et al., 2004; Lo and Cheung, 2005; Puttaraju et al., 2006; Yu et al., 2006; Dubost et al., 
2007; Lee et al., 2007b; Ribeiro et al., 2007; Barros et al., 2008; Savoie et al., 2008; 
Tsai et al., 2008; RongYao et al., 2009; Abdullah et al., 2011; Yeh et al., 2011). The 
percentage of scavenging radicals is dependent on the initial DPPH radical 
concentration; however, EC50 depends on initial concentrations of free radicals, and 
the kinetic reaction between DPPH and antioxidants is not linear to DPPH  
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concentration. Trolox was used as a calibrating standard expressed as trolox 
equivalents which correlated very well with the biological redox properties of 
phenolics (Sánchez-Moreno, 2002; Stratil et al., 2006). Since phenolic compounds are 
processed in mushrooms, it could be considered that the antioxidant activity of 
mushrooms is related to the proportion of phenolic compounds present (Wada et al., 
1996; Cheung et al., 2003). In this current study, the antioxidant ability of aqueous 
mushroom extracts were reported in TE/g instead of EC50 since it is more accurate to 
use the absorbance variation (Karadag et al., 2009). 
Phenols are known to be effective antioxidants; therefore, the high contents of 
total phenolic compounds in extracts were responsible for their effective antioxidant 
properties. In this current study, the TEAC, DPPH and FRAP of culinary mushrooms 
(hot- and cold-water extraction) were positively correlated with phenolic contents. On 
the other hand, for the medicinal mushrooms, the correlation analysis of FRAP and 
total phenolic content showed no significant correlation between hot-water extraction 
and FRAP value. There have been several investigations of antioxidant activity in 
medicinal herbs and plants showing that phenolic compounds play an important role 
in protecting oxidation damage (Bocco et al., 1998;  Gazzani et al., 1998; 
Triantaphyllou, 2001; Zheng and Wang, 2001; Katalinic et al., 2006; Wong et al., 
2006a; Wojdylo et al., 2007; Sulaiman et al., 2010). It also has been reported that 
plant and mushroom antioxidant abilities were well correlated with the proportion of 
phenolic compounds present (Visioli et al., 1998; Zheng and Wang, 2001; Puttaraju et 
al., 2006; Wong et al., 2006a; Turkoglu et al., 2007; Wojdylo et al., 2007; Kim et al., 
2008). However, some authors have reported that there was not such a direct 
correlation between antioxidant activates and total phenol contents (Bocco et al., 1998; 
Kähkönen et al., 1999; Capecka et al., 2005; Hinneburg et al., 2006). A study of A. 
bisporus reported that strain Bs0633 had the highest phenolic concentrations in the 
extracts; however, it had the lowest antioxidant activity (Savoie et al., 2008). 
The relationship between total polyphenols and total antioxidant activities is 
contradictory. Many studies have reported conflicting results between the potential 
natural antioxidant compounds and total phenolic contents because of the antioxidant 
assay methods that are used to evaluate antioxidant activity. 
Antioxidant properties might be enhanced or decreased depending on their 
cultivation or environmental conditions, developmental stage, species, variety, storage 
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condition and so on (Kang and Saltveit, 2002). The loss of potential antioxidant 
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compounds during the extraction process may reflect the different antioxidant 
activities between hot- and cold-water extracts (Gazzani et al., 1998; Sun and Ho, 
2005). Therefore, it is difficult to compare all these results unless they are based on 
the same assay and extraction process. 
However, even when the same test is applied, the measurement of antioxidant 
values may vary from one study to another (Dávalos et al., 2004). This makes it 
difficult to make comparisons with previous reported data; also, the results are 
expressed in various ways, so the antioxidant activities of pure phenolic compounds 
are scattered in the literature and difficult to compare (Villano et al., 2005). The 
different extraction procedures, the quantities of extracts used in the reaction mixtures 
and the data expression are diverse in different published articles; therefore, it is 
difficult to compare the present results with published data on antioxidant activities in 
mushroom extracts. 
It is obvious that it is not a simple matter to predict a full picture of the quality or 
quantity of the phenolic constituents in extracts by using the Folin-Ciocalteu 
procedure. Some compounds such as sugars and ascorbic acid may affect the results 
of a Folin-Ciocalteu assay. Therefore, it is difficult to predict the antioxidant activity 
based on the amount of total phenolic compounds present (Singleton and Rossi Jr, 
1965; Kähkönen et al., 1999). Estimation of antioxidant capacity is dependent on the 
assays used. There is no single method that can lead to a complete evaluation of 
antioxidant activity in the extracts. The relationship between the antioxidant or 
scavenging activity and phenolic content is very difficult to establish using statistical 
tools because: 1. the antioxidant properties of single compounds within a group can 
vary remarkably so that the same levels of phenolics do not necessarily correspond to 
the same antioxidant responses; 2. the different methods used to determine the 
antioxidant activity are based on different mechanisms of reaction so that they often 
give different results; and 3. extracts are very complex mixtures of many different 
compounds with distinct polarity as well as antioxidant and pro-oxidant properties, 
sometimes showing synergistic actions by comparison with individual compounds 
(Parejo et al., 2002). 
 152 
Table 4.1: Extraction solvent and antioxidant methods of published articles. 
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F-C: Folin-ciocalteu phenol reagent. 
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4.2 In vitro enzymatic digestion 
Metabolism and excretion 
In order to access the bloodstream for systemic distribution, phenolic compounds 
must pass through the enterocytes (Coulston and Boushey, 2008). Aglycones and free 
simple phenolic compounds, flavonoids (quercetin, genistein) and phenolic acid can 
be directly absorbed through the small intestinal mucosa (Bravo, 2009). However, the 
intestinal mechanisms of GI absorption of phenolic compounds tract remain unknown. 
It has been suggested that probably the phenolic compounds are too hydrophilic to 
penetrate the gut wall (Manach et al., 2004), and it is believed that the absorption of 
phenolic compounds into the enterocytes occurs through the action of monocarboxylic 
acid transporters, as well as by passive diffusion (Manach et al., 2004; Coulston and 
Boushey, 2008). 
In the food matrix, expect for flavones, glycosylated forms are found in all 
flavonoids, and the absorption is influenced by glycosylation. Even so, the fate of 
glycoside in the stomach is not clear (Manach et al., 2004). Phenolic compounds are 
the substrates for the body’s detoxification system. The detoxification system seeks to 
reduce the potential toxicity of foreign compounds, such as xenobiotic compounds, by 
metabolizing them to make them more readily excreted or to reduce their bioactivity. 
This detoxification system is composed of three primary activities: Phase I, II and III 
metabolism. 
Phase I typically involves hydroxylation which is performed by cytochrome 
p450, a membrane-bound enzyme. The hydroxylation renders a hydroxyl group to 
substrates, which is a step of functionalization resulting in the substrates being more 
reactive for subsequent metabolism, such as phase II. Phase II involves a conjunction 
reaction in which a hydroxyl group on the foreign compound is modified by adding a 
sulphate, glucuronic acid or methyl group, and decreases the potential toxicity of 
xenobiotic compounds and facilitates their exretion into bile and/or urine by the liver 
and kidney. These reactions can occur at any phenol group on the molecule. Phase III, 
finally, involves the efflux of both native xenobiotics or phase I/II metabolites from 
the enterocyte as a means of lowering their intracellular concentration. 
Polyphenols absorbed from the intestinal lumen by enterocytes occur in the 
phase II detoxification reaction in the cell interior. Polyphenols may be the circulated 
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into the liver by the portal vein prior to systemic circulation and extracted from the 
bloodstream by the kidneys and subsequently excreted in the urine (Coulston and 
Boushey, 2008; Bravo, 2009). 
 
 
 
Figure 4.2 Metabolism of substituted and unsubtituted phenols (Sipes). 
In vitro antioxidant assay 
Bio-availability refers to the fraction of an ingested nutrient that is available to 
the body for use in normal physiological functions or storage (Duthie et al., 2000). To 
exert a protective effect against free radical related diseases, potential antioxidant 
compounds have to be absorbed from the gut. To facilitate the evaluation of 
antioxidant compounds, in vitro enzymatic digestion models have been designed to 
simulate the human digestion system. Occurrence of oxidation and the action of 
antioxidants have different chemical and physical mechanisms. Three different in 
vitro antioxidant assays (TEAC, DPPH and FRAP) have been employed after a 
simulated GI digestion. Various foods, meals and supplements have been subjected to 
in vitro enzymatic digestion procedures to analyse the stability of antioxidants 
(Pérez-Vicente et al., 2002; Vallejo et al., 2004; Nagah and Seal, 2005; 
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Bermúdez-Soto et al., 2007). Since there are no studies to date that have provided 
information regarding the availability of antioxidants in selected mushroom extracts 
after digestion, this current study has provided information about the stability of 
potential antioxidants in mushroom extracts following digestion. By measuring the 
antioxidant activity of mushroom extracts after the in vitro digestion, it is possible to 
provide more biologically relevant data detailing the antioxidant properties of 
mushroom extracts. 
In conclusion, according to the results presented by the TEAC, DPPH and FRAP 
assays, the potential antioxidant compounds of all of the mushrooms extracts studied 
could be released after enzymatic digestion, except for C. militaris. This suggests that 
potential bio-available antioxidant compounds may have been bound or associated 
with the soluble fraction of mushroom material, and most of the potential antioxidant 
compounds from the mushroom extracts would be released and their antioxidant 
activity increased under different pH conditions and enzymatic hydrolysis. In addition, 
there was no significant increase in the current study between the initial TEAC values 
of the A. auricula (the hot-water extract) and H. erinaceus (the cold-water extract) 
extracts and the TEAC values after in vitro digestion. A study of B. edulis showed 
similar result. The scavenging ABTS free radical ability of B. edulis did not 
significantly increase after digestion (Soler‐Rivas et al., 2009). Although not 
measured using the TEAC assay, a study of fresh orange and apple juice also showed 
that there were no significant differences between the initial and the post-digestion 
FRAP values (Ryan and Prescott, 2010). 
This observation suggests that potential antioxidant compounds in these 
mushroom extracts are resistant to GI treatment, and the in vitro enzymatic digestion 
process gives an estimated value of the antioxidant capacity of the potential 
antioxidant compounds that would be released and made available in an accessible 
form to be absorbed during digestion, and provide protection from oxidative damage 
within the gut lumen and intestinal mucosa (Nagah and Seal, 2005; Toor et al., 2008). 
An increase in the antioxidant activity of mushroom extracts after enzymatic 
digestion has been reported by other researchers. In a study of A. bisporus and L. 
edodes, the ability to scavenge ATBS free radicals was found to increase significantly 
after in vitro digestion. The scavenging ability of DPPH free radicals by A. bisporus, 
157 
 
B. edulis and L. edodes was increased after in vitro digestion (Soler‐Rivas et al., 2009). 
Generally, in this current study, the aqueous mushroom extracts showed potential 
antioxidant ability while those of C. militaris showed decreased activity after in vitro 
enzymatic digestion in all antioxidant assays. This suggests that the degrading of 
potential antioxidant compounds in C. militaris extracts occurred during in vitro 
enzymatic digestion. This loss of antioxidant compounds after digestion steps has also 
been reported by Bermúdez-Soto et al. (2007). Polyphenols have been found to be 
highly sensitive to alkaline conditions, therefore, the degraded antioxidants in the 
extracts may potentially undergo slight structural transformation in different pH 
environments (Bermúdez-Soto et al., 2007; Ryan and Prescott, 2010). A numbers of 
studies on polyphenols, β-carotene and vitamin E have shown that the bio-availability 
of antioxidants in the small intestine could be very low (Burton and Traber, 1990; 
Clifford, 2004; Novotny et al., 2005). 
A study of commercially available fruit juices showed that the FRAP value of 
fresh grapefruit and pineapple juice were significantly lower post digestion (Ryan and 
Prescott, 2010). Another study of pomegranate juice and broccoli discovered that the 
concentration of phenolic compound (anthocyanins and caffeolyquinic acid) were also 
significantly decreased after pancreatin-bile salt digestion (Pérez-Vicente et al., 2002; 
Vallejo et al., 2004). In studies of standard phenolic compounds, phenols (gallic acid, 
vanillic acid and caffeic acid) were rather stable compared with other phenolic 
compounds (catechin, rutin and quercetin) after gastric treatment. However, the 
concentration of gallic acid diminished by nearly 50% due to the pH value under 
intestinal conditions and the absorptivity of gallic acid was highly influenced by pH. 
Moreover, in an intestinal medium, the concentration of catechin, epicatechin, rutin, 
quercetin and kaempferol showed clear decreases (Troncoso, 2001). In addition, the 
decrease of antioxidant compounds was found in chokeberry, raspberry and red wine 
(McDougall et al., 2005a; McDougall et al., 2005b; Bermúdez-Soto et al., 2007). The 
processing of mushroom extracts can influence antioxidant activity results. Taking 
into consideration the different pH values in the medium may partially explain the 
losses of antioxidant ability. 
It had been reported that after in vitro gastric digestion, total and individual 
simple phenolic acid, hydroxycinnamic acid derivatives and total sinapic and ferulic 
derivatives levels of broccoli extracts showed decreases (Vallejo et al., 2004). The 
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decrease of the level of potential antioxidant compounds after in vitro GI digestion 
has also been reported (Gil-Izquierdo et al., 2002; Pérez-Vicente et al., 2002; Vallejo 
et al., 2004). Vallejo et al. (2004) suggested that it is possible that pancreatin digestion 
liberates compounds able to associate with potential antioxidant compounds. In a 
study of mushroom phenolic compound concentration, Kim et al. (2008) reported that 
the phenolic acid level of mushrooms was higher than that of flavonoids (Kim et al., 
2008). Polysaccharide extracted from mushrooms also showed antioxidant ability (Liu 
et al., 1997; Yu et al., 2006; Tseng et al., 2008). Therefore, polysaccharide degradation 
might also liberate antioxidants bounded to their complex structure exposing them to 
unfavourable media. Frontela et al. (2011) also suggested that it cannot be easily 
explained why there is a decrease in total phenolic content value after in vitro GI 
digestion between samples (Frontela et al., 2011). 
Despite the decrease of antioxidant ability in C. militaris after in vitro enzymatic 
digestion, the increased antioxidant activity in all the other mushroom extracts after 
pancreatin digestion could perhaps be explained by the ability of mushroom extracts 
to produce more antioxidant compounds by hydrogen bonding and the subsequent 
release of these antioxidant compounds during enzymatic hydrolysis (McDougall et 
al., 2005b). Similar results showing an increase of antioxidant activity after digestion 
steps have also been found in various vegetables, fruit juices and whole grain food 
(Nagah and Seal, 2005; Ryan and Prescott, 2010; Wootton-Beard et al., 2011). This 
could be explained by the availability of antioxidant compounds during the first stage 
of the digestion process (Serrano et al., 2007). This may suggest that the potential 
antioxidant ability of antioxidant compounds in mushroom extracts would be more 
effective after digestion. 
Soler‐Rivas et al. (2009) and Ganguli et al. (2007) suggested that the longer a 
heat treatment was applied, the lower the antioxidant properties appeared on 
mushroom fruiting bodies (Ganguli et al., 2007; Soler‐Rivas et al., 2009). It has been 
reported that the presence of protein and iron interacted with green tea polyphenols 
during in vitro enzymatic digestion resulting in a decrease of antioxidant ability 
(Alexandropoulou et al., 2006).Troncoso (2001) reported that the concentration of 
gallic acid and kaempferol were not affected after gastric treatment (HCl-pepsin 
treatment). However, when the phenolic compounds were submitted to intestinal 
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treatment (NaOH-pancreatin), the concentrations were clearly decreased (Table 4.3) 
(Troncoso, 2001). It is therefore likely that the potential antioxidant compounds 
within mushroom extracts may have undergone slight structural transformation, and 
therefore went undetected by the antioxidant method of analysis resulting in the 
various antioxidant values in each of the in vitro enzymatic digestion steps. 
In general, the results obtained from the TEAC, DPPH and FRAP assays used in this 
study show that the mushroom extracts showed different antioxidant release 
patterns during in vitro enzymatic digestion. The variation in results may be because 
of the characteristic chemistry within each mushroom, and the fact that the chemical 
mechanisms behind each antioxidant assay are different (Nagah and Seal, 2005). 
In brief, according to the results of the TEAC, FRAP and DPPH assays used in 
this study, potential antioxidant compounds of mushrooms extracts are resistant to in 
vitro enzymatic digestion (GI treatment), and release more potential antioxidant 
compounds that contribute to their total antioxidant activity. It may also suggest that 
the significantly lower post-digestion activity of C. militaris may suggest that the 
potential antioxidant compounds of C. militaris are unstable and easily degraded in 
the human GI tract. 
Table 4.3: Phenolic compounds after gastric and intestinal treatment, modified 
from Troncoso (2001). 
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4.3 Cellular antioxidant activity assay 
The cellular antioxidant quality of potential antioxidant compounds was 
determined for the mushrooms from their cellular antioxidant activity values. The 
effect of mushroom extracts on the prevention of oxidative damage to cells has not 
previously been reported. Compared with the chemical reagent assays, hot-water 
extracts of mushrooms had statistically positive relationships between the cellular 
antioxidant activity and the total phenolic content for mushrooms (p<0.01). A similar 
positive correlation has been found in fruits (Wolfe and Liu, 2007). In FRAP (the 
hot-water extracts) and TEAC assays (the cold-water extracts), mushroom extracts 
were found to be positively correlated with cellular antioxidant activities. 
The absence of correlation between the total phenolic content (cold-water 
extracts), TEAC (hot-water extracts), FRAP (cold-water extracts), DPPH (both hot- 
and cold-water extracts) and cellular antioxidant activity was also found in the ORAC 
assay. Studies on common vegetables and broccoli extracts have demonstrated no 
agreement between ORAC and cellular antioxidant activities (Eberhardt et al., 2005; 
Song et al., 2010). This lack of correlation is likely to be due to the biological 
components of cellular antioxidant assays (Faulkner and Fridovich, 1993; Wolfe and 
Liu, 2007). It has also been reported that there was no significant correlation between 
ORAC value and cellular antioxidant activity in a study of standard flavonoids. Rutin 
and naringenin had high ORAC values but no activity on cellular antioxidant assay 
(Wolfe and Liu, 2008). On the other hand, galangin and epigallocatechin gallate had 
low ORAC values but they exhibited high activity in cellular antioxidant activity 
(Wolfe and Liu, 2008). The hot-water extract of mushroom T. versicolor in this study 
had significantly higher cellular antioxidant activity compared with the both hot- and 
cold-water extract of P. citrinopileatus (p<0.001), while in the chemical assays (total 
phenolic content, TEAC and DPPH), P. citrinopileatus exhibited higher antioxidant 
activity than C. versicolor (p<0.001). A similar result was also found in H. erinaceus. 
H. erinaceus had higher antioxidant activity in the chemical assays than A. 
auricula-judae, and G. lucidum, however; H. erinaceus had the lowest cellular 
antioxidant activity in both hot-and cold-water extracts. The permeability of 
membrane of potential antioxidant compounds is structure-depend. For example, 
polyphenolic compounds are thought to be the majority of exogenous antioxidants 
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which provide a protective effect against lipid oxidation. According to their chemical 
structures, flavanols are more hydrophobic than flavanones but in a liposomal 
membrane affinity test by fluorescence-quenching measurement, the membrane 
affinity of flavonols was greater than that of flavonoids (figure 4.1) (Oteiza et al., 
2005). Therefore, the present data suggest that the chemical assays’ estimates of 
potential antioxidants in the mushroom extract do not accurately reflect the 
antioxidant activity within cultured human cells. 
 
Figure 4.1 Chemical structures of the flavanol and flavanone. 
The cellular model of antioxidant activity assay has been used in the study of cell 
uptake, metabolism and distribution of flavonoids (Spencer et al., 2004). Although 
cellular antioxidant assays are more time consuming and require more equipment 
compared with chemical assays, they may more closely reflect the potential 
antioxidant components of mushroom extract activity within a biological environment 
(Eberhardt et al., 2005). Since the cellular antioxidant assay mimics the cellular 
processes of the potential antioxidant compounds by penetrating into the cells and 
reacting with free radicals that occur in vivo, the cellular antioxidant assay has more 
relevance to biological systems compared with chemical assays. The ability of 
potential antioxidant compounds to prevent lipid oxidation could be influenced by 
many interacting factors. For example, in biological membranes, ascorbic acid 
regenerates oxidized α-tocopherol to reactivate α-tocopherol. The antioxidant polar 
paradox hypothesis is not able to consistently predict the ability of antioxidant 
compounds to inhibit lipid oxidation in an oil/water emulsion. For instance, BHT and 
α-tocopherol are essentially not water soluble, however they do not inhibit lipid 
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oxidation in the corn oil in water emulsions. In contrast, gallic acid has been shown to 
be an effective antioxidant in corn oil in water emulsions (Alamed et al., 2009). 
Cellular antioxidant activity values demonstrate some aspects of cell uptake, 
metabolism and the distribution of bioactive compounds, which are important 
modulators of bioactivity. This study provides more biologically relevant data on 
potential antioxidant compounds in mushroom extracts. Cellular measurements reflect 
antioxidant activities measured in whole animals and are shown to relate to health 
benefits (Crespy and Williamson, 2004). In this study, the potential antioxidant 
compounds of mushroom extracts moved beyond the measurement of simple 
chemical reactions towards a more complex biological system. Using cell-based 
testing systems in vitro would perhaps eliminate many of the limitations of chemical 
interaction-based assays. 
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Chapter 5 Conclusion and further work 
With the remarkable enhancement of people’s living standards coupled with the 
large growing ageing population, people in Taiwan are becoming more interested in 
diet and health and the demand for health-preserving foods is growing rapidly. In 
China and Taiwan, crude drugs have been used for centuries to enhance health and to 
prevent disease. Most consumption of mushrooms is based on traditional ways of 
preparation such as a tea, soup or beverage for the maintenance of health. A complex 
mixture of antioxidants is contained in food and beverages. For this reason, it is 
important to understand the composition and nutritional value of these products 
(Garcia-Salas et al., 2010). Infusion and decoction in water are the traditional methods 
for the preparation of mushrooms for culinary and medicinal use. This is a simply a 
way to mimic the ethnomedicinal methods used in folk therapies and to approximate 
the levels of antioxidants in mushrooms that might be taken and absorbed during 
normal dietary consumption (Triantaphyllou, 2001; Zheng and Wang, 2001). 
In this study, the mushroom extracts were prepared in ways which mimicked the 
methods used in traditional folk medicine (Triantaphyllou, 2001), and were based on 
the traditional way of ingestion and preparation of crude material in China and Taiwan. 
For use in foods, extracts made with water are appropriate, less toxic, nutritionally 
more relevant and would have obvious advantages in relation to certification, 
practicality and safety (Wong et al., 2006b). 
The Trolox equivalent antioxidant capacity (TEAC) parameter in ABTS free 
radical assay as well as DPPH assaying methods used in this investigation offers the 
benefit of allowing comparisons to be made with other food and plant materials 
examined by other authors. In genral, different antioxidant compounds have different 
chemical structures and features, therefore, it is clear that the variation in antioxidant 
activity detected by different methods depended on the nature of the oxidants and 
antioxidants and the chemistry involved in the reaction, reducing ability (in FRAP), 
and scavenging ability (in TEAC and DPPH). 
The hydrolysable phenolic is believed to be partially hydrolysed during the 
digestion processes. The release of polyphenols of whole-grain cereal foods may also 
increase during digestion and cause the increase of antioxidant activity after digestion 
(Nagah and Seal, 2005). These results are important because they suggest that 
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antioxidants exert their effect within the digestive tract and provide an environment 
which protects the intestinal epithelium from pro-oxidative compounds (Fardet et al., 
2008). Antioxidants may act as anticarcinogenic agents because they stimulate 
detoxification systems, especially phase II of the conjugation reaction. For example, 
the formation of carcinogens can be prevented by caffeic acid and ferulic acid and this 
blocks the interaction between carcinogens and critical cell macromolecules (Fardet et 
al., 2008). 
In general, it can be concluded that the potential antioxidant compounds of the 
mushroom extracts were clearly affected by the in vitro digestion process. The amount 
of accessible antioxidant compounds from the mushroom extracts was found to be 
`much higher after in vitro digestion. According to the results presented, consumption 
of mushroom extracts may provide some degree of antioxidant property and further 
provide potential protection against oxidative damage, which is considered to cause 
arteriosclerosis and neurodegeneration. In vitro enzymatic digestion mimics the 
conditions in the human GI tract showing that the amount of antioxidant released from 
mushroom extracts into the human intestine may be higher than expected from the 
values predicted by chemical measurements. It suggests that antioxidants encounter an 
acidic medium in the stomach and will be substantially exposed to and reach higher 
antioxidant activity in the small intestine. It is therefore clear that the digestion 
process is an important factor influencing the antioxidant activity of selected 
mushrooms. 
It suggests that proteolytic and pancreatic enzyme activity, and perhaps changes 
in pH, might generate new or more antioxidant compounds which have higher 
antioxidant activity than the original extracts (Soler‐Rivas et al., 2009). The results of 
increase of antioxidant activity of selected mushroom extracts after digestion are 
important because they suggest that antioxidants exert their effect within the digestive 
tract and provide an environment which protects the intestinal epithelium from 
pro-oxidative compounds. In this current study, the enzymatic digestion steps give an 
estimate of the amount of potential antioxidant compounds in the mushrooms extracts 
that are available in an accessible form to be absorbed into the human mucosa. Study 
of in vitro digestion can therefore be used as a useful screen to examine the 
accessibility of antioxidants (Toor et al., 2008). 
The present data obtained from chemical and cellular assays suggest that 
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estimates of the potential antioxidant activity of mushroom extracts may not 
accurately reflect the antioxidant activity within cultured human cells.  Whether 
chemical assays reveal the extent of the actual antioxidant activity value of P. 
citrinopileatus and H. erinaceus or the activity of the antioxidant complex of A. 
auricula-judae, T. versicolor and G. lucidum were not efficiently shown in the 
chemical assays. The results of cellular antioxidant assays relate to cellular estimates 
of antioxidant activity within cells. Hence, in this stage, the results suggest that the 
actual antioxidant activity of T. versicolor could be much more than chemical reaction. 
In addition, this might help to explain that the ancient medicinal belief regarding C. 
militaris and T. versicolor is perhaps partly due to their potent antioxidant activity. 
C. militaris exhibited more promising antioxidant potential than the other five 
mushrooms studied in chemical assays (phenolic content, TEAC, FRAP and DPPH) 
and cellular antioxidant assay. The most interesting aspect of this study was the in 
vitro digestion step and cellular antioxidants, which demonstrated the possible 
antioxidant activity within the human GI tract and the cell uptake and distribution. C. 
militaris showed a significant decrease after in vitro digestion steps, however, in the 
cellular antioxidant assays, it showed much higher cellular antioxidant values than the 
other five mushrooms (p<0.001). To the author’s knowledge, there have been no 
previous studies which have demonstrated these data. 
The benefits of the consumption of an antioxidant rich diet have been in doubt 
recently (Halliwell and Gutteridge, 2007). An epidemiological study in the 
Netherlands found an inverse correlation between heart disease and stroke and the 
dietary intake of flavonoids, which originate from tea, fruits and vegetables (Hertog et 
al., 1993; Halliwell and Gutteridge, 2007). A number of intervention trials have found 
that antioxidants failed to demonstrate benefits in humans (Rimm et al., 1993; 
Stampfer et al., 1993; Knekt et al., 1994; Halliwell and Gutteridge, 2007). These 
findings could be explained first by the suggestion that ROS may not actually be 
involved in some diseases and that antioxidants cannot encompass all symptoms. 
Second, in intervention trials, the subjects already have extensive pathology. Finally, 
the applied dosage may be wrong. 
The evidence has shown that a low dosage of antioxidants might have more 
benefit than higher dosages of single agents. The uptake of other nutrients such as 
α-tocopherol and β-carotene might be interfered with at high doses of single agents 
(Halliwell, 2009). The timing of antioxidant administration may be also critical. For 
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example, vitamin C showed beneficial effects on processes in the early stage of 
atherosclerosis; however, if atherosclerotic plaques are already formed, the  
anti-atherogenic benefits of vitamin C may be negligible (Aguirre and May, 2008). 
Moreover, some clinical studies have been carried out on patients who were already 
suffering from vascular disease (Hodis et al., 1995; Azen et al., 1996). Further, if 
administration of antioxidants does not decrease the oxidative damage when diseases 
occur, then antioxidants will not have an effect on the diseases. One animal study 
showed benefits in murine models of amyotrophic lateral sclerosis, but not in human 
patients (Halliwell, 2001; Schnabel, 2008). 
Another study of chronic obstructive pulmonary disease using several 
pharmacological antioxidants such as Erdosteine and Fudosteine suggested that these 
compounds may affect important outcomes in chronic obstructive pulmonary disease, 
such as steroid resistance, mucus hypersecretion and inflammation (Rahman and 
MacNee, 2012). Therefore, antioxidants may actually work in humans and act in the 
correct sites, such as crossing the blood/brain barrier, and terminate oxidative damage 
at those sites (Halliwell, 2009). Even so, in some studies, the health benefits of 
antioxidants such as β-carotene and vitamin E are ambiguous and paradoxical 
(Pearson et al., 2006; Halliwell and Gutteridge, 2007). Before extensive breeding 
programmes are undertaken to increase the understanding of antioxidant activity in 
vivo for mushroom extracts, it is necessary to estimate the antioxidant activity which 
reflects clinical effects and to carry out feeding studies to determine the benefit of 
antioxidant levels of mushroom extracts used as alternative remedies. 
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Further studies 
The focus of this study has been to evaluate the antioxidant activity of selected 
mushrooms. According to cellular antioxidant assay, the medical mushroom, C. 
militaris showed the most potent antioxidant activity in this thesis. The results of in 
vitro tests obtained here can be used in evaluating the likelihood of antioxidant effects 
of mushroom extracts in vivo. The results also clearly show that the mushroom 
extracts have a wide range of antioxidant activity in different antioxidant approaches 
and the potential antioxidant compounds of mushroom extracts might contribute a 
certain degree of therapeutic benefits as alternative therapies for conditions such as 
neurodegeneration. Many studies have suggested that neurodegeneration is related to 
oxidative stress (Sayre et al., 1997; Keller et al., 2005; Castellani et al., 2006; 
Halliwell, 2009). A report has indicated that a high dosage of α-tocopherol could 
delay the deterioration of patients with Alzheimer’s disease (AD), however, in patients 
with a progression of mild-cognitive impairment from AD, the same dose had no 
effect (Blacker, 2005; Halliwell, 2006). Therefore one major future research area is 
developing a novel antioxidant for neurodegenerative diseases (Castellani et al., 2006). 
Further identification, fractionation and isolation of the biologically-active chemical 
constituents are also required. Studies using in vivo models will lead to the estimation 
and standardization of the dosage, and to the distribution and excretion profile of 
these mushroom extracts under physiological conditions, and if the spectrum of 
potential antioxidant compounds is broad enough and the dosage low enough, they 
might be used as prophylactic agents. Small animal models could be the first step of 
such an in vivo study. Therefore, an investigation of the potential neuroprotective 
properties of mushroom extracts could be done by using mice (AD model). 
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